stemmacolore

Pubblicazioni anno corrente

Pubblicazioni anno corrente

Pubblicazioni IOV anno corrente 2020
TitoloAutoriRivista
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancerManca,P., Corallo,S., Randon,G., Lonardi Sara, Cremolini,C., Rimassa,L., Bergamo,F., Antoniotti,C., Smiroldo,V., Zaniboni,A., Murialdo,R., Tampellini,M., Tomasello,G., Clavarezza,M., Racca,P., Antista,M., Raimondi,A., Prisciandaro,M., Pagani,F., Palermo,F. (…)European Journal of Cancer
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 PatientsZattoni,F., Ravelli,I., Rensi,M., Capobianco,D., Borsatti,E., Baresic,T., Chiaravalloti,A., Schillaci,O., Alongi,P., Bartolotta,T. V., Rambaldi,I., Bartolomei,M., Farsad,M., Tredici,M., Donner,D., Chierichetti,F., Trifirò,G., Brugola,E., Burei Marta, Dal Moro,F. (…)Clinical nuclear medicine
A case of ‘double hit’ mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinibScapinello,G., Riva,M., Branca,A., Pizzi,M., Bonaldi Laura, Martines Annalisa, Manni,S., Visentin,A., Trentin,L., Semenzato,G., Gurrieri,C., Piazza,F.Annals of hematology
A Contemporary Case Series of Complex Surgical Repair of Surgical/Endoscopic Injuries to the Abdominal UreterFicarra,V., Rossanese,M., CRESTANI ALESSANDRO, Caloggero,S., Alario,G., Novara,G., Giannarini,G., Valotto,C.European urology focus
A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19Nalesso,F., Garzotto Francesco, Cattarin,L., Gobbi,L., Qassim,L., Sgarabotto,L., Tiberio,I., Calò. A.Journal of clinical medicine
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with RegorafenibSantangelo,A., Rossato,M., Lombardi Giuseppe, Benfatto,S., Lavezzari,D., De Salvo Gian Luca, Indraccolo Stefano, Dechecchi,M. C., Prandini,P., Gambari,R., Scapoli,C., Di Gennaro,G., Caccese Mario, Eoli,M., Rudà ,R., Brandes,A. A., Ibrahim,T., Rizzato,S., Lolli,I., Lippi,G. (…)Neuro-Oncology
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?Silvestris,N., Apolone,G., Botti,G., Ciliberto,G., Costantini,M., De Paoli,P., Franceschi,S., Opocher Giuseppe, Paradiso,A., Pronzato,P., Sgambato,A., De Maria,R.Journal of Experimental & Clinical Cancer Research
A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) PatientsCortiula,F., Pasello Giulia, Follador,A., Nardo Giorgia, Polo,V., Scquizzato,E., Conte,A. D., Miorin,M., Giovanis,P., D’Urso,A., Girlando,S., Settanni,G., Picece,V., Veccia,A., Corvaja,C., Indraccolo Stefano, De Maglio,G.Diagnostics (Basel)
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluationPrat,A., Guarneri Valentina, Parè,L., Griguolo Gaia, Pascual,T., Dieci Maria Vittoria, Chic,N., Gonzalez-Farrè,B., Frassoldati,A., Sanfeliu,E., Cejalvo,J. M., Munoz,M., Bisagni,G., Braso-Maristany,F., Urso,L., Vidal,M., Brandes,A. A., Adamo,B., Musolino,A., MIGLIETTA FEDERICA (…)Lancet Oncology
A new landscape for systemic pharmacotherapy of recurrent glioblastoma?Lombardi Giuseppe, Idbaih,A., Le Rhun,E., Preusser,M., Zagonel Vittorina, French,P.Cancers
A new standard of care for patients with high-risk rhabdomyosarcoma? – Authors’ replyBisogno,G., Ferrari,A., Melcon,S. G., De Salvo Gian Luca, Bergeron,C., Jenney,M.Lancet Oncology
A Novel MAX Gene Mutation Variant in a Patient With Multiple and ‘Composite’ Neuroendocrine-Neuroblastic TumorsPozza,C., Sesti,F., Di Dato,C., Sbardella,E., Pofi,R., Schiavi Francesca, Bonifacio,V., Isidori,A. M., Faggiano,A., Lenzi,A., Giannetta,E.Frontiers in endocrinology
A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancerMiyamoto,Y., Schirripa Marta, Suenaga,M., Cao,S., Zhang,W., Okazaki,S., Berger,M. D., Matsusaka,S., Yang,D., Ning,Y., Baba,H., Loupakis Fotios, Lonardi Sara, Pietrantonio,F., Borelli,B., Cremolini,C., Yamaguchi,T., Lenz,H. J.PLoS ONE
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsBerger,M. D., Ning,Y., Stintzing,S., Heinemann,V., Cao,S., Zhang,W., Yang,D., Miyamoto,Y., Suenaga,M., Schirripa Marta, Hanna,D. L., Soni,S., Puccini,A., Tokunaga,R., Naseem,M., Battaglin,F., Cremolini,C., Falcone,A., Loupakis Fotios, Lenz,H. -J (…)European Journal of Cancer
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR TrialPeters,S., Danson,S., Hasan,B., Dafni,U., Reinmuth,N., Majem,M., Tournoy,K. G., Mark,M. T., Pless,M., Cobo,M., Rodriguez-Abreu,D., Falchero,L., Moran,T., Ortega Granados,A. L., Monnet,I., Mohorcic,K., Sureda,B. M., Betticher,D., Demedts,I., Macias,J. A. (…)Journal of thoracic oncology
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasksPalmerini,P., Dalla Pietà, A., Sommaggio Roberta, Ventura,A., Astori,G., Chieregato,K., Tisi,M. C., Visco,C., Perbellini,O., Ruggeri,M., Cappuzzello,E., Rosato AntonioCYTOTHERAPY
A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urineClausen,T. M., Kumar,G., Ibsen,E. K., Orum-Madsen,M. S., Hurtado-Coll,A., Gustavsson,T., Agerbaek,M. Ø., Gatto,F., Todenhofer,T., Basso Umberto, Knowles,M. A., Sanchez-Carbayo,M., Salanti,A., Black,P. C., Daugaard,M.Cell Death Discovery
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma PatientsRastrelli Marco, Del Fiore Santo Paolo, Buja,A., Vecchiato Antonella, Rossi Carlo Riccardo, Chiarion-Sileni Vanna, Tropea Saveria, Russano Francesco, Zorzi,M., Spina Romina, Cappellesso,R., Mazzarotto,R., Cavallin,F., Bassetto,F., Bezzon,E., Ferrazzi,B., Alaibac,M., Mocellin SimoneFrontiers in Oncology
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)Johnston,S. R. D., Harbeck,N., Hegg,R., Toi,M., Martin,M., Shao,Z. M., Zhang,Q. Y., Martinez Rodriguez,J. L., Campone,M., Hamilton,E., Sohn,J., Guarneri Valentina, Okada,M., Boyle,F., Neven,P., Cortés,J., Huober,J., Wardley,A., Tolaney,S. M., Cicin,I. (…)Journal of Clinical Oncology
Ablation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 studySimioni,A., Valpione,S., Granziera Elisa, Rossi,C. R., Cavallin,F., Spina Romina, Sieni,E., Aliberti,C., Stramare,R., Campana,L. G.Scientific Reports
Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential PathogenesisBertolini,A., van de Peppel,I. P., Bodewes,F. A. J. A., Moshage,H., Fantin Alberto, Farinati,F., Fiorotto,R., Jonker,J. W., Strazzabosco,M., Verkade,H. J., Peserico GiuliaHepatology
Accuracy of mammography dosimetry in the era of the European Directive 2013/59/Euratom transpositionGennaro Gisella Maria, Bigolaro,S., Hill,M. L., Stramare,R., Caumo FrancescaEuropean Journal of Radiology
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian rare cancer networkStacchiotti,S., Simeone,N., Lo Vullo,S., Baldi,G. G., Brunello Antonella, Vincenzi,B., Palassini,E., Dagrada,G., Collini,P., Morosi,C., Greco,F. G., Sbaraglia,M., Dei Tos,A. P., Mariani,L., Frezza,A. M., Casali,P. G.Cancer
Acute heart failure in parathyreotoxicosisBattistella,E., Pomba Luca, Toniato AntonioEndocrine
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in EuropeVrdoljak,E., Gligorov,J., Wierinck,L., Conte PierFranco, De Grève,J., Meunier,F., Palmieri,C., Travado,L., Walker,A., Wiseman,T., Wuerstlein,R., Alba,E., Biurrún,C., D’Antona,R., Sola-Morales,O., Ubaysi,C., Ventura,R., Cardoso,F.Breast
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancerBanna,G. L., Urzia,V., Benanti,C., Pitrè,A., Lipari,H., Di Quattro,R., De Giorgi,U., Schepisi,G., Basso Umberto, Bimbatti,D., Rundo,F., Libra,M., Malatino,L.Supportive Care in Cancer
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trialDummer,R., Brase,J. C., Garrett,J., Campbell,C. D., Gasal,E., Squires,M., Gusenleitner,D., Santinami,M., Atkinson,V., Mandalà ,M., Chiarion-Sileni Vanna, Flaherty,K., Larkin,J., Robert,C., Kefford,R., Kirkwood,J. M., Hauschild,A., Schadendorf,D., Long,G. V.Lancet Oncology
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trialAscierto,P. A., Del Vecchio,M., Mandalá,M., Gogas,H., Arance,A. M., Dalle,S., Cowey,C. L., Schenker,M., Grob,J. J., Chiarion-Sileni Vanna, Márquez-Rodas,I., Butler,M. O., Maio,M., Middleton,M. R., de la Cruz-Merino,L., Arenberger,P., Atkinson,V., Hill,A., Fecher,L. A., Millward,M. (…)Lancet Oncology
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cellsSommaggio Roberta, Cappuzzello,E., Dalla Pietà ,A., Tosi,A., Palmerini,P., Carpanese Debora, Nicolè,L., Rosato AntonioOncoimmunology
Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East ItalyDel Mistro Annarosa, Frayle – Salamanca Helena, Menegaldo,A., Favaretto,N., GORI SILVIA, Nicolai,P., Spinato,G., Romeo,S., Tirelli,G., da Mosto,M. C., Polesel,J., Boscolo Rizzo,P.Scientific Reports
Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patientsAngioni,R., Sanchez-Rodri­guez,R., Munari,F., Bertoldi,N., Arcidiacono Diletta, Cavinato,S., Marturano,D., Zaramella,A., Realdon Stefano, Cattelan,A., Viola,A., Molon,B.Cell Death & Disease
Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During TreatmentBoldrin Elisa, Curtarello Matteo, Fassan,M., Rugge,M., Realdon Stefano, Alfieri Rita, Amadori Alberto, Saggioro DanielaFrontiers in Oncology
Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: Final Overall Survival Results From SOLAR-1Andrè,F., Ciruelos,E. M., Juric,D., Loibl,S., Campone,M., Mayer,I. A., Rubovszky,G., Yamashita,T., Kaufman,B., Lu,Y. S., Inoue,K., Papai,Z., Takahashi,M., Ghaznawi,F., Mills,D., Kaper,M., Miller,M., Conte PierFranco, Iwata,H., Rugo,H. S. (…)Annals of Oncology
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groupsGallego,S., Chi,Y. Y., De Salvo Gian Luca, Li,M., Merks,J. H. M., Rodeberg,D. A., van Scheltinga,S. T., Mascarenhas,L., Orbach,D., Jenney,M., Million,L., Minard-Colin,V., Wolden,S., Zanetti,I., Parham,D. M., Mandeville,H., Venkatramani,R., Bisogno,G., Hawkins,D. S., European paediatric Soft tissue sarcoma Study Grou (…)Pediatric Blood & Cancer
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45Bjelic-Radisic,V., Cardoso,F., Cameron,D., Brain,E., Kuljanic,K., da Costa,R. A., Conroy,T., Inwald,E. C., Serpentini Samantha, Pinto,M., Weis,J., Morag,O., Lindviksmoen Astrup,G., Tomaszweksi,K. A., Pogoda,K., Sinai,P., Sprangers,M., Aaronson,N., Velikova,G., Greimel,E. (…)Annals of Oncology
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on SurvivalMannavola,F., Mandala,M., Todisco,A., Chiarion-Sileni Vanna, Palla,M., Minisini,A. M., Pala,L., Morgese,F., Di Guardo,L., Stucci,L. S., Guida,M., Indini,A., Quaglino,P., Ferraresi,V., Marconcini,R., Tronconi,M. C., Rossi,E., Nigro,O., Occelli,M., Cortellini,A. (…)Frontiers in Oncology
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the ‘Pamerit’ studyMosca,A., De Giorgi,U., Procopio,G., Basso Umberto, Cartenì,G., Bersanelli,M., Naglieri,E., Galli,L., Caffo,O., Fornarini,G., Boccardo,F., Porta,C.Japanese journal of clinical oncology
An objective comparison of detection and segmentation algorithms for artefacts in clinical endoscopyAli,S., Zhou,F., Braden,B., Bailey,A., Yang,S., Cheng,G., Zhang,P., Li,X., Kayser,M., Soberanis-Mukul,R., Albarqouni,S., Wang,X., Wang,C., Watanabe,S., Oksuz,I., Ning,Q., Yang,S., Khan,M. A., Gao,X. W., Realdon Stefano (…)Scientific Reports
Analysis of morbidity and mortality, quality of life and bowel function after total colectomy with ileorectal anastomosis versus right and left hemicolectomy: A study to optimise the treatment of lynch syndrome and attenuated polyposis coliUrso,E. D. L., Celotto,F., Giandomenico,F., Gavaruzzi,T., Del Bianco Paola, Lotto,L., Spolverato,G., Pucciarelli,S., Bao,Q. R.European Journal of Surgical Oncology
Anaplastic Astrocytoma: State of the art and future directionsCaccese Mario, Padovan,M., D’Avella,D., Chioffi,F., Gardiman,M. P., Berti Franco, Busato,F., Bellu Luisa, Bergo Eleonora, Zoccarato,M., Fassan,M., Zagonel Vittorina, Lombardi GiuseppeCritical reviews in oncology/hematology
Anti-PD1 antibodies in patients aged ? 75 years with metastatic melanoma: A retrospective multicentre studyRidolfi,L., De Rosa,F., Petracci,E., Tanda,E. T., Marra,E., Pigozzo Jacopo, Marconcini,R., Guida,M., Cappellini,G. C. A., Gallizzi,G., Occelli,M., Pala,L., Gambale,E., Bersanelli,M., Galdo,G., Cortellini,A., Morgese,F., Zoratto,F., Stucci,L. S., Strippoli,S. (…)Journal of Geriatric Oncology
Anti-Proliferative and Pro-Apoptotic Effects of Short-Term Inhibition of Telomerase In Vivo and in Human Malignant B Cells Xenografted in ZebrafishGiunco,S., Zangrossi,M., Dal Pozzolo,F., Celeghin,A., Ballin,G., Petrara,M. R., Amin,A., Argenton,F., Godinho Ferreira,M., De Rossi AnitaCancers
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate CancerMontagner Monia Isabella, Penna,A., Fracasso,G., Carpanese Debora, Pietà,A. D., Barbieri,V., Zuccolotto,G., Rosato AntonioCells
Are the Italian Children Exposed to Advertisements of Nutritionally Appropriate Foods?Nucci Daniele, Rabica,F., Dallagiacoma,G., Fatigoni,C., Gianfredi,V.Foods
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical TrialPetrelli,F., Labianca,R., Zaniboni,A., Lonardi Sara, Galli,F., Rulli,E., Rosati,G., Corallo,S., Ronzoni,M., Cardellino,G. G., Mattioli,R., Mambrini,A., Ciuffreda,L., Banzi,M., Pusceddu,V., Maiello,E., Zampino,M., Zagonel Vittorina, Marchetti,P., Corsi,D. (…)JAMA ONCOLOGY
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE StudyCasadei-Gardini,A., Marisi,G., Dadduzio Vincenzo, Gramantieri,L., Faloppi,L., Ulivi,P., Foschi,F. G., Tamburini,E., Vivaldi,C., Rizzato,M. D., Ielasi,L., Canale,M., Conti,F., Rudnas,B., Fornaro,L., Silvestris,N., Silletta,M., Cardellino,G. G., Lonardi Sara, Fornari,F. (…)Clinical Cancer Research
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)Gelsomino,F., Lamberti,G., Tiseo,M., Rocco,D., Pasello Giulia, Cecere,F. L., Chella,A., Grilli,G., Mandruzzato,M., Tognetto,M., Garassino,M. C., Macerelli,M., Novello,S., Roila,F., Colantonio,I., Grossi,F., Fiorentino,M., Ardizzoni,A.Therapeutic advances in medical oncology
AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancerAntoniotti,C., Borelli,B., Rossini,D., Pietrantonio,F., Morano,F., Salvatore,L., Lonardi Sara, Marmorino,F., Tamberi,S., Corallo,S., Tortora,G., Bergamo Francesca, Brunella,D. S., Boccaccino,A., Grassi,E., Racca,P., Tamburini,E., Aprile,G., Moretto,R., Boni,L. (…)BMC cancer
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancerNicolazzo,C., Loreni,F., Caponnetto,S., Magri,V., Vestri,A. R., Zamarchi Rita, Gradilone,A., Facchinetti Antonella, Rossi Elisabetta, Cortesi,E., Gazzaniga,P.Oncotarget
Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt deliveryMatha,K., Lollo,G., Taurino,G., Respaud,R., Marigo Ilaria , Shariati,M., Bussolati,O., Vermeulen,A., Remaut,K., Benoit,J. -PEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Biological Aging and Immune Senescence in Children with Perinatally Acquired HIVDalzini,A., Petrara,M. R., Ballin,G., Zanchetta Marisa, Giaquinto,C., De Rossi AnitaJournal of Immunology Research
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptorsDieci Maria Vittoria, Miglietta,F., Griguolo Gaia, Guarneri ValentinaCancer treatment reviews
Biomimetic cellular vectors for enhancing drug delivery to the lungsEvangelopoulos,M., Yazdi,I. K., Acciardo,S., Palomba,R., Giordano,F., Pasto’ Anna, Sushnitha,M., Martinez,J. O., Basu,N., Torres,A., Hmaidan,S., Parodi,A., Tasciotti,E.Scientific Reports
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective studyRutkowski,P., Indini,A., De Luca,M., Merelli,B., Mariuk-Jarema,A., Teterycz,P., Rogala,P., Lugowska,I., Cybulska-Stopa,B., Labianca,A., Di Guardo,L., Del Vecchio,M., Pigozzo Jacopo, Randon,G., Corti,F., Tondini,C. A., Rulli,E., Mandala,M.Journal for immunotherapy of cancer
Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) Navarria,P., Minniti,G., Clerici,E., Comito,T., Cozzi,S., Pinzi,V., Fariselli,L., Ciammella,P., Scoccianti,S., Borzillo,V., Anselmo,P., Maranzano,E., Dell’acqua,V., Jereczek-Fossa,B., Giaj Levra,N., Podlesko,A. M., Giudice,E., Buglione di Monale E Bastia,M., Pedretti,S., Bruni,A. (…)The British journal of radiology
Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRMPediconi,F., Galati,F., Bernardi,D., Belli,P., Brancato,B., Calabrese,M., Camera,L., Carbonaro,L. A., Caumo Francesca, Clauser,P., Girardi,V., Iacconi,C., Martincich,L., Panizza,P., Petrillo,A., Schiaffino,S., Tagliafico,A., Trimboli,R. M., Zuiani,C., Sardanelli,F. (…)Radiologia Medica
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional AnalysisIacovelli,R., Ciccarese,C., Facchini,G., Milella,M., Urbano,F., Basso Umberto, De Giorgi,U., Sabbatini,R., Santini,D., Berardi,R., Santoni,M., Bracarda,S., Massari,F., Masini,C., De Tursi,M., Ricotta,R., Buti,S., Zustovich,F., Sepe,P., Rossetti,S. (…)Targeted Oncology
Can Vascular Endothelial Growth Factors and CD34 Expression Implement NICE (Narrow-Band Imaging International Colorectal Endoscopic) Classification in Colorectal Polypoid Lesion Diagnosis?Ruffolo,C., Ferrara,F., Trevellin,E., Cataldo,I., Fornasier,C., Pozza,A., Campo Dell’Orto,M., Angriman,I., Dei Tos,A. P., Bardini,R., Massani,M., Kotsafti Andromachi, Scarpa,M.European Surgical Research
Cancer and COVID-19: what do we really know?Poortmans,P. M., Guarneri Valentina, Cardoso,M. -JLancet
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists’ perspectiveLambertini,M., Toss,A., Passaro,A., Criscitiello,C., Cremolini,C., Cardone,C., Loupakis Fotios, Viscardi,G., Meattini,I., Dieci Maria Vittoria, Ferrara,R., Giusti,R., Maio,M. D.ESMO Open
Caring for Patients with Advanced Stage Cancer at the Time of COVID-19Brunello Antonella, Zagonel VittorinaOncologist
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic CholangiocarcinomaSabbatino,F., Liguori,L., Malapelle,U., Schiavi Francesca, Tortora,V., Conti,V., Filippelli,A., Tortora,G., Ferrone,C. R., Pepe,S.Frontiers in Oncology
Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and LapatinibSartore-Bianchi,A., Lonardi Sara, Aglietta,M., Martino,C., Ciardiello,F., Marsoni,S., Siena,S.JAMA ONCOLOGY
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Silvestri,V., Leslie,G., Barnes,D. R., and the CIMBA Group, Agnarsson,B. A., Aittomäki,K., Alducci Elisa, Andrulis,I. L., Barkardottir,R. B., Barroso,A., Barrowdale,D., Benitez,J., Bonanni,B., Borg,A., Buys,S. S., Caldés,T., Caligo,M. A., Capalbo,C., Campbell,I., Chung,W. K. (…)JAMA ONCOLOGY
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?Menis Jessica, Reck,M.Journal of thoracic oncology
Chronic use of statins and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysisFacciorusso,A., Crinò,S. F., Tacelli,M., Antonini,F., Fantin Alberto, Barresi,L.Expert Review of Gastroenterology & Hepatology
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trialMeessen,J. M. T. A., Cardinale,D., Ciceri,F., Sandri,M. T., Civelli,M., Bottazzi,B., Cucchi,G., Menatti,E., Mangiavacchi,M., Condorelli,G., Barbieri,E., Gori,S., Colombo,A., Curigliano,G., Salvatici,M., Pastori,P., Ghisoni,F., Bianchi Alessandra, Falci Cristina, Cortesi,P. (…)European Society of Cardiology Heart Failure Association
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesisFassan,M., Realdon Stefano, Cascione,L., Hahne,J. C., Munari Giada, Guzzardo,V., Arcidiacono Diletta, Lampis,A., Brignola,S., Dal Santo,L., Agostini,M., Bracon,C., Maddalo,G., Scarpa,M., Farinati,F., Zaninotto,G., Valeri,N., Rugge,M.Pathology, research and practice
Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysisTonello Marco, Barina,A., Turchet Federica, De Simoni,O., Alfieri Rita, Franzato Boris, Gruppo Mario, Dengo Bruno, Deffenu Davide, Di Pasquale Daniele, Fiore Tania, Pietropaoli Claudia, Munaron Susanna, Zanardo Giorgio, Sommariva Antonio, Pilati PierluigiUpdates in surgery
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World ExperienceBonanno Laura, Pavan,A., Ferro,A., Calvetti,L., Frega Stefano, Pasello Giulia, Aprile,G., Guarneri Valentina, Conte PierFranco, Rete Oncologica Veneta (ROV)Oncologist
Clinical Management of Diffuse Low-Grade GliomasLombardi Giuseppe, Barresi,V., Castellano,A., Tabouret,E., Pasqualetti,F., Salvalaggio,A., Cerretti,G., Caccese Mario, Padovan,M., Zagonel Vittorina, Ius,T.Cancers
Clinical pathways for urology patients during the COVID-19 pandemicSimonato,A., Giannarini,G., Abrate,A., Bartoletti,R., CRESTANI ALESSANDRO, De Nunzio,C., Gregori,A., Liguori,G., Novara,G., Pavan,N., Trombetta,C., Tubaro,A., Porpiglia,F., Ficarra,V., Research Urology Network (RUN)Minerva urologica e nefrologica
Cobimetinib plus atezolizumab in BRAF(V600) wild-type melanoma: primary results from the randomized phase 3 IMspire170 studyGogas,H., Dreno,B., Larkin,J., Demidov,L., Stroyakovskiy,D., Eroglu,Z., Ferrucci,P. F., Pigozzo Jacopo, Rutkowski,P., Mackiewicz,J., Rooney,I., Voulgari,A., Troutman,S., Pitcher,B., Guo,Y., Yan,Y., Castro,M., Mulla,S., Flaherty,K., Arance,A. (…)Annals of Oncology
Colonic J-Pouch or Straight Colorectal Reconstruction After Low Anterior Resection For Rectal Cancer: Impact on Quality of Life and Bowel Function: A Multicenter Prospective Randomized StudyGavaruzzi,T., Pace,U., Giandomenico,F., Pucciarelli,S., Bianco,F., Selvaggi,F., Restivo,A., Asteria,C. R., Morpurgo,E., Cuicchi,D., Jovine,E., Coletta,D., La Torre,G., Amato,A., Chiappa,A., Marchegiani,F., Rega,D., De Franciscis,S., Pellino,G., Zorcolo,L. (…)Diseases of the Colon & Rectum
Colonoscopy related adverse events and mortality in an Italian organized colorectal cancer screening programBenazzato,L., Zorzi,M., Antonelli,G., Guzzinati,S., Hassan,C., Fantin AlbertoEndoscopy
Combination of Immunotherapy and Radiotherapy – The Next Magic Step in the Management of Lung Cancer?Hendriks,L. E. L., Menis Jessica, De Ruysscher,D. K. M., Reck,M.Journal of thoracic oncology
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancerBarat,A., Smeets,D., Moran,B., Zhang,W., Cao,S., Das,S., Klinger,R., Betge,J., Murphy,V., Bacon,O., Kay,E. W., Van Grieken,N. C. T., Verheul,H. M. W., Gaiser,T., Schulte,N., Ebert,M. P., Fender,B., Hennessy,B. T., McNamara,D. A., O’Connor,D. (…)Scientific Reports
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung CancerBoscolo,A., Fortarezza,F., Lunardi,F., Comacchio,G., Urso, L., Frega Stefano, Menis Jessica, Bonanno Laura, Guarneri Valentina, Rea,F., Conte PierFranco, Calabrese,F., Pasello GiuliaFrontiers in Oncology
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screeningCuzick,J., Adcock,R., Carozzi,F., Gillio-Tos,A., De Marco,L., Del Mistro Annarosa, Frayle – Salamanca Helena, Girlando,S., Sani,C., Confortini,M., Zorzi,M., Giorgi-Rossi,P., Rizzolo,R., Ronco,G., the New Technologies for Cervical Cancer ScreeningInternational Journal of Cancer
Comparison between 18f-Dopa and 18f-Fet Pet/Ct in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and our ExperienceEvangelista, L., Cuppari, L., Bellu Luisa, Bertin Daniele, Caccese Mario, Reccia Pasquale, Zagonel Vittorina, Lombardi GiuseppeCurrent radiopharmaceuticals
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian CancerMazzoldi Elena Laura, Pastò,A., Pilotto Giorgia, Minuzzo,S., Piga,I., Palumbo,P., Carella,M., Frezzini,S., Nicoletto Maria Ornella, Amadori Alberto, Indraccolo StefanoJournal of clinical medicine
Complete mesocolic excision versus conventional hemicolectomy in patients with right colon cancer: a systematic review and meta-analysisDe Simoni,O., Barina,A., Sommariva Antonio, Tonello Marco, Gruppo Mario, Mattara Genny, Toniato Antonio, Pilati Pierluigi, Franzato BorisInternational journal of colorectal disease
Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GISTNannini,M., Valerio,D. S., Gruppioni,E., Altimari,A., Chiusole Benedetta, Saponara,M., Pantaleo,M. A., Brunello AntonellaTherapeutic advances in gastroenterology
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experiencePierantoni,F., Basso Umberto, Maruzzo Marco, Lamberti,E., Bimbatti Davide, Tierno Giuseppina, Bergo Eleonora, Brunello Antonella, Zagonel VittorinaJournal of Geriatric Oncology
Computed tomography features predicting aggressiveness of malignant parenchymal renal tumors suitable for partial nephrectomy: a reviewFicarra,V., Caloggero,S., Rossanese,M., Giannarini,G., CRESTANI ALESSANDRO, Ascenti,G., Novara,G., Porpiglia,F.Minerva urologica e nefrologica
Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy studyParrozzani,R., Lombardi Giuseppe, Midena,E., Leonardi,F., Londei,D., Padovan,M., Caccese Mario, Marchione,G., Bini,S., Zagonel Vittorina, Frizziero,L.Therapeutic advances in medical oncology
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective StudyVitale,M. G., Pipitone,S., Venturelli,M., Baldessari,C., Porta,C., Iannuzzi,F., Basso Umberto, Scagliarini,S., Zucali,P. A., Galli,L., Rossetti,S., Caserta,C., Bracarda,S., Iacovelli,R., Masini,C., Cortellini,A., Di Girolamo,S., Buti,S., Fornarini,G., Carrozza,F. (…)Clinical genitourinary cancer
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyGarassino,M. C., Whisenant,J. G., Huang,L. C., Trama,A., Torri,V., Agustoni,F., Baena,J., Banna,G., Berardi,R., Bettini,A. C., Bria,E., Brighenti,M., Cadranel,J., De Toma,A., Chini,C., Cortellini,A., Felip,E., Finocchiaro,G., Garrido,P., Genova,C. (…)Lancet Oncology
COVID-19: ensuring our medical equipment can meet the challengeGarzotto Francesco, Ceresola,E., Panagiotakopoulou Sofia, Spina,G., Menotto,F., Benozzi,M., Casarotto,M., Lanera,C., Bonavina Maria Giuseppina, Gregori,D., Meneghesso,G., Opocher GiuseppeExpert review of medical devices
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia disseminationTosello Valeria, Bongiovanni,D., Liu,J., Pan,Q., Yan,K. K., Saccomani,V., Van Trimpont,M., Pizzi,M., Mazzoni,M., Dei Tos,A. P., Amadori Alberto, Zanovello Paola, Van Vlierberghe,P., Yu,J., Piovan ErichLeukemia
Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemiaBongiovanni,D., Tosello Valeria, Saccomani,V., Dalla Santa,S., Amadori Alberto, Zanovello,P., Piovan ErichOncogene
Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)Brennan,B., Zanetti,I., De Salvo Gian Luca, Orbach,D., Gallego,S., Francotte,N., Schifflers,S., Van Noesel,M., Kelsey,A., Casanova,M., Dagrada,G. P., Collini,P., Zin,A., Santoro,L., Ferrari,A.Pediatric Blood & Cancer
Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic AssayMenegaldo,A., Schroeder,L., Holzinger,D., Tirelli,G., Dal Cin,E., Tofanelli,M., Rigo,S., Mantovani,M., Stellin,M., Del Mistro Annarosa, Dei Tos,A. P., Guerriero,A., Niero,M., Borsetto,D., Da Mosto,M. C., Polesel,J., Pawlita,M., Waterboer,T., Boscolo-Rizzo,P.LARYNGOSCOPE
Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma PatientsBoldrin Elisa, Curtarello Matteo, Dallan,M., Alfieri Rita, Realdon Stefano, Fassan,M., Saggioro DanielaInternational Journal of Molecular Sciences
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane AntigenCarpanese Debora, Ferro-Flores,G., Ocampo-Garcia,B., Santos-Cuevas,C., Salvarese,N., Figini,M., Fracasso,G., De Nardo,L., Bolzati,C., Rosato Antonio, Melendez-Alafort LauraScientific Reports
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelinesPassiglia,F., Bertolaccini,L., Del Re,M., Facchinetti,F., Ferrara,R., Franchina,T., Malapelle,U., Menis Jessica, Passaro,A., Pilotto,S., Ramella,S., Rossi,G., Trisolini,R., Novello,S.Critical reviews in oncology/hematology
Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncologySommariva Antonio, Ansaloni,L., Baiocchi,G. L., Cascinu,S., Cirocchi,R., Coccolini,F., Deraco,M., Fiorentini,G., Gelmini,R., Di Giorgio,A., Lippolis,P. V., Pasqual,E. M., Sassaroli,C., Macrì,A., Sammartino,P., Scaringi,S., Valle,M., Vaira,M.European Journal of Surgical Oncology
Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysisBuja,A., Rivera,M., De Polo,A., Zorzi,M., Baracco,M., Italiano,I., Vecchiato Antonella, Del Fiore Santo Paolo, Guzzinati,S., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoEuropean Journal of Surgical Oncology
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomasMerli,M., Marino Dario, Cencini,E., Rattotti,S., Fraenza,C., Grossi,P., Bianchi,B., Mora,B., Sciarra,R., Finotto Silvia, Mecacci,B., Passamonti,F., Visco,C., Arcaini,L.HEMATOLOGICAL ONCOLOGY
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerPantano,F., Rossi Elisabetta, Iuliani,M., Facchinetti Antonella, Simonetti,S., Ribelli,G., Zoccoli,A., Vincenzi,B., Tonini,G., Zamarchi Rita, Santini,D.Scientific Reports
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast CancerBrisotto,G., Biscontin,E., Rossi Elisabetta, Bulfoni,M., Piruska,A., Spazzapan,S., Poggiana Cristina, Vidotto Riccardo, Steffan,A., Colombatti,A., Huck,W. T. S., Cesselli,D., Zamarchi Rita, Turetta,M., Del Ben,F.Cancers
E-Coaching: the DianaWeb study to prevent breast cancer recurrencesGianfredi,V., Nucci Daniele, Balzarini,M., Acito,M., Moretti,M., Villarini,A., Villarini,M.La Clinica terapeutica
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancerZulato Elisabetta, Attili,I., Pavan,A., Nardo Giorgia, Del Bianco Paola, Boscolo Bragadin,A., Verza Martina, Pasqualini Lorenza, Pasello Giulia, Fassan,M., Calabrese,F., Guarneri Valentina, Amadori Alberto, Conte PierFranco, Indraccolo Stefano, Bonanno LauraBritish Journal of Cancer
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerVaidya,J. S., Bulsara,M., Saunders,C., Flyger,H., Tobias,J. S., Corica,T., Massarut,S., Wenz,F., Pigorsch,S., Alvarado,M., Douek,M., Eiermann,W., Brew-Graves,C., Williams,N., Potyka,I., Roberts,N., Bernstein,M., Brown,D., Sperk,E., Laws,S. (…)JAMA ONCOLOGY
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancerBiganzoli,L., Cinieri,S., Berardi,R., Pedersini,R., McCartney,A., Minisini,A. M., Caremoli,E. R., Spazzapan,S., Magnolfi,E., Brunello Antonella, Risi,E., Palumbo,R., Leo,S., Colleoni,M., Donati,S., De Placido,S., Orlando,L., Pistelli,M., Parolin,V., Mislang,A. (…)Breast cancer research : BCR
Effectiveness of CBCT imaging during radiotherapy for the detection of initial COVID-19 lung diseaseSepulcri Matteo, Paronetto,C., El Khouzai,B., Novo,A., Aldegheri,V., Scaggion Alessandro, Fusella MarcoAdvances in radiation oncology
Effects of Popular Diets on Anthropometric and Cardiometabolic Parameters: An Umbrella Review of Meta-Analyses of Randomized Controlled TrialsDinu,M., Pagliai,G., Angelino,D., Rosi,A., Dall’Asta,M., Bresciani,L., Ferraris,C., Guglielmetti,M., Godos,J., Del Bo’,C., Nucci Daniele, Meroni,E., Landini,L., Martini,D., Sofi,F.Advances in Nutrition
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectivesSartori,G., Belluomini,L., Lombardo,F., Avancini,A., Trestini,I., Vita,E., Tregnago,D., Menis Jessica, Bria,E., Milella,M., Pilotto,S.Expert Review of Anticancer Therapy
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenPietrantonio,F., Loupakis Fotios, Randon,G., Raimondi,A., Salati,M., Trapani,D., Pagani,F., Depretis Ilaria, Maddalena,G., Morano,F., Corallo,S., Prisciandaro,M., Corti,F., Guarini,V., Bocconi,A., Marra,A., Belli,C., Spallanzani,A., Fassan,M., Lonardi Sara (…)Oncologist
Endoscopic radiofrequency ablation for the treatment of severe gastric antral vascular ectasia in patients with cirrhosisSenzolo,M., Realdon Stefano, Zanetto,A., Simoncin,B., Schepis,F., Caronna,S., Saracco,G. M., De Angelis,C. G., Debernardi Venon,W.European Journal of Gastroenterology & Hepatology
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY surveyPezzilli,R., Buscarini,E., Pollini,T., Bonamini,D., Marchegiani,G., Crippa,S., Belfiori,G., Sperti,C., Moletta,L., Pozza,G., De Nucci,G., Manes,G., Mandelli,E. D., Casadei,R., Ricci,C., Alicante,S., Vattiato,C., Carrara,S., Di Leo,M., Fabbri,C. (…)Digestive and Liver Disease
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancerGriguolo Gaia, Brasò-Maristany,F., Gonzàlez-Farrè,B., Pascual,T., Chic,N., Saurì­,T., Kates,R., Gluz,O., Martìnez,D., Parè,L., Tsvetkova,V., Pesantez,D., Vidal,M., Adamo,B., Munoz,M., Galvàn,P., Barberà,L., Cuatrecasas,M., Christgen,M., Kreipe,H. (…)Cancers
Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experienceZoccarato,M., Basile,A. M., Padovan Maria, Caccese Mario, Zagonel Vittorina, Lombardi GiuseppeThe International journal of neuroscience
ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO Guidelines CommitteeMichielin,O., van Akkooi,A., Lorigan,P., Ascierto,P. A., Dummer,R., Robert,C., Arance,A., Blank,C. U., Chiarion-Sileni Vanna, Donia,M., Faries,M. B., Gaudy-Marqueste,C., Gogas,H., Grob,J. J., Guckenberger,M., Haanen,J., Hayes,A. J., Hoeller,C., Lebbé,C., Lugowska,I. (…)Annals of Oncology
ESMO consensus conference recommendations on the management of metastatic melanoma: the ESMO Guidelines CommitteeKeilholz,U., Ascierto,P. A., Dummer,R., Robert,C., Lorigan,P., van Akkooi,A., Arance,A., Blank,C. U., Chiarion-Sileni Vanna, Donia,M., Faries,M. B., Gaudy-Marqueste,C., Gogas,H., Grob,J. J., Guckenberger,M., Haanen,J., Hayes,A. J., Hoeller,C., Lebbé,C., Lugowska,I. (…)Annals of Oncology
Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease modelBuja,A., Rivera,M., De Polo,A., Brino,E. D., Marchetti,M., Scioni,M., Pasello Giulia, Bortolami Alberto, Rebba,V., Schiavon,M., Calabrese,F., Mandoliti,G., Baldo,V., Conte PierFrancoThoracic Cancer
Evaluating nephrocheck as a predictive tool for acute kidney injuryNalesso,F., Cattarin,L., Gobbi,L., Fragasso,A., Garzotto Francesco, Calò,L. A.International journal of nephrology and renovascular disease
Evaluation of nutritional quality of biscuits and sweet snacks sold on the Italian market: The Food Labelling of Italian Products (FLIP) studyDall’Asta,M., Rosi,A., Angelino,D., Pellegrini,N., Martini,D., Nucci Daniele, Paolella,G., Ruggiero,E., Pignone,V., Moccia,S., Spagnuolo,C., Dello Russo,M.PUBLIC HEALTH NUTRITION
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT databaseSalem,M. E., Yin,J., Goldberg,R. M., Pederson,L. D., Wolmark,N., Alberts,S. R., Taieb,J., Marshall,J. L., Lonardi Sara, Yoshino,T., Kerr,R. S., Yothers,G., Grothey,A., Andre,T., De Gramont,A., Shi,Q.Annals of Oncology
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET populationCiruelos,E., Jerusalem,G., Martin,M., Tjan-Heijnen,V., Neven,P., Gavila,J., Montemurro,F., Generali,D., Lang,I., Martì­nez-Serrano,M. J., Perellò,M. F., Conte PierFrancoClinical & Translational Oncology
Evolving use of liquid biopsy in non-small-cell-lung cancer patientsIndraccolo StefanoInternational Journal of Biological Markers
Extent of primary DNA damage measured by the comet assay in health professionals exposed to antineoplastic drugs: A systematic review and meta-analysisGianfredi,V., Nucci Daniele, Fatigoni,C., Salvatori,T., Villarini,M., Moretti,M.International Journal of Environmental Research and Public Health
Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two InstitutionsChiusole Benedetta, Le Cesne,A., Rastrelli Marco, Maruzzo Marco, Lorenzi,M., Cappellesso,R., Del Fiore Santo Paolo, Imbevaro Silvia, Sbaraglia,M., Terrier,P., Ruggieri,P., Dei Tos,A. P., Rossi Carlo Riccardo, Zagonel Vittorina, Brunello AntonellaFrontiers in Oncology
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: Results from an international, multi-institutional, retrospective analysisNapolitano,A., Provenzano,S., Colombo,C., Vitellaro,M., Brunello Antonella, Badalamenti,G., Nannini,M., Ibrahim,T., Hohenberger,P., Gasperoni,S., Gennatas,S., Jones,R. L., Hindi,N., Martin-Broto,J., Spalato Ceruso,M., Silletta,M., Dei Tos,A. P., Gronchi,A., Stacchiotti,S., Santini,D. (…)ESMO Open
Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case reportDionese,M., Pierantoni,F., Maruzzo Marco, Bimbatti,D., Deppieri,F. M., Maran,M., Gardiman,M. P., Basso UmbertoAnti-Cancer Drugs
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesFachal,L., Aschard,H., Beesley,J., Barnes,D. R., Allen,J., Kar,S., Pooley,K. A., Dennis,J., Michailidou,K., Turman,C., Soucy,P., Lemaçon,A., Lush,M., Tyrer,J. P., Ghoussaini,M., Marjaneh,M. M., Jiang,X., Agata Simona, Aittomäki,K, Alonso,M. R. (…)Nature genetics
First-line immune-chemotherapy combination for squamous NSCLC is already a realityHendriks,L. E. L., Menis Jessica, Remon,J.Translational lung cancer research
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaDummer,R., Hauschild,A., Santinami,M., Atkinson,V., Mandalà ,M., Kirkwood,J. M., Chiarion-Sileni Vanna, Larkin,J., Nyakas,M., Dutriaux,C., Haydon,A., Robert,C., Mortier,L., Schachter,J., Lesimple,T., Plummer,R., Dasgupta,K., Gasal,E., Tan,M., Long,G. V. (…)The New England Journal of Medicine
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced MelanomaRobert,C., Long,G. V., Brady,B., Dutriaux,C., Di Giacomo,A. M., Mortier,L., Rutkowski,P., Hassel,J. C., McNeil,C. M., Kalinka,E. A., Lebbé,C., Charles,J., Hernberg,M. M., Savage,K. J., Chiarion-Sileni Vanna, Mihalcioiu,C., Mauch,C., Arance,A., Cognetti,F., Ny,L. (…)Journal of Clinical Oncology
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancerNeuzillet,C., Casadei-Gardini,A., Brieau,B., Vivaldi,C., Brandi,G., Tougeron,D., Filippi,R., Vienot,A., Silvestris,N., Pointet,A. L., Lonardi Sara, Rousseau,B., Scartozzi,M., Dahan,L., Aprile,G., Le Sourd,S., Evesque,L., Meurisse,A., Lièvre,A., Vernerey,D. (…)International Journal of Cancer
FOLFOXIRI-bevacizumab or FOLFOX-panitumumab in left-sided RAS/BRAF wild-type metastatic colorectal cancer patients: a propensity score-based analysisPietrantonio,F., Fucà ,G., Rossini,D., Schmoll,H. J., Bendell,J. C., Morano,F., Antoniotti,C., Corallo,S., Borelli,B., Raimondi,A., Marmorino,F., Niger,M., Boccaccino,A., Masi,G., Lonardi Sara, Boni,L., de Braud,F., Di Bartolomeo,M., Falcone,A., Cremolini,C. (…)Oncologist
Free-to-use DIR solutions in radiotherapy: Benchmark against commercial platforms through a contour-propagation studyScaggion Alessandro, Fiandra,C., Loi,G., Vecchi,C., Fusella MarcoPhysica Medica
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapyGiampieri,R., Ziranu,P., Daniele,B., Zizzi,A., Ferrari,D., Lonardi Sara, Zaniboni,A., Cavanna,L., Rosati,G., Casagrande,M., Pella,N., Demurtas,L., Zampino,M. G., Sozzi,P., Pusceddu,V., Germano,D., Lai,E., Zagonel Vittorina, Libertini,M., Puzzoni,M. (…)Cancers
Functional properties and sequence variation of HTLV-1 p13Omsland,M., Silic-Benussi Micol, Moles,R., Sarkis,S., Purcell,D. F. J., Yurick,D., Khoury,G., D’Agostino,D. M., Ciminale Vincenzo, Franchini,G.Retrovirology
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and futureGottardi Michele, Sperotto,A., Ghelli Luserna Di Rorà,A., Padella,A., Cangini,D., Giannini,M. B., Simonetti,G., Martinelli,G., Cerchione,C.Minerva Medica
Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell LineElbadawy,H. M., Mohammed Abdul,M. I., Aljuhani,N., Vitiello,A., Ciccarese Francesco, Shaker,M. A., Eltahir,H. M., Palù,G., Di Antonio,V., Ghassabian,H., Del Vecchio,C., Salata,C., Franchin,E., Ponterio,E., Bahashwan,S., Thabet,K., Abouzied,M. M., Shehata,A. M., Parolin,C., Calistri,A. (…)Viruses-Basel
Genetic perturbation of IFN-? transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesisCiccarese Francesco, Grassi Angela, Pasqualini,L., Rosano,S., Noghero,A., Montenegro,F., Bussolino,F., Di Camillo,B., Finesso,L., Toffolo,G. M., Mitola,S., Indraccolo StefanoComputational and Structural Biotechnology Journal
Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer PatientsRampazzo,E., Cecchin,E., Del Bianco Paola, Menin Chiara, Spolverato,G., Giunco,S., Lonardi Sara, Malacrida,S., De Paoli,A., Toffoli,G., Pucciarelli,S., De Rossi AnitaCancers
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibilityLandi,M. T., Bishop,D. T., MacGregor,S., Machiela,M. J., Stratigos,A. J., Ghiorzo,P., Brossard,M., Calista,D., Choi,J., Fargnoli,M. C., Zhang,T., Rodolfo,M., Trower,A. J., Menin,C., Martinez,J., Hadjisavvas,A., Song,L., Stefanaki,I., Scolyer,R., Yang,R. (…)Nature genetics
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analysesZhang,H., Ahearn,T. U., Lecarpentier,J., Barnes,D., Beesley,J., Qi,G., Jiang,X., O’Mara,T. A., Zhao,N., Bolla,M. K., Dunning,A. M., Dennis,J., Wang,Q., Ful,Z. A., Aittomäki,K., Andrulis,I. L., Anton-Culver,H., Arndt,V., Aronson,K. J., Arun,B. K. (…)Nature genetics
Germline polymorphisms of circadian genes and gastric cancer predispositionRajendran,S., Benna,C., Marchet,A., Nitti,D., Mocellin SimoneCancer Communications
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumabRuzzo,A., Graziano,F., Bagaloni,I., Di Bartolomeo,M., Prisciandaro,M., Aprile,G., Ongaro,E., Vincenzi,B., Perrone,G., Santini,D., Fornaro,L., Vivaldi,C., Tomasello,G., Loupakis Fotios, Lonardi Sara, Fassan,M., Valmasoni,M., Sarti,D., Lorenzini,P., Catalano,V. (…)Gastric Cancer
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeCohen,R., Vernerey,D., Bellera,C., Meurisse,A., Henriques,J., Paoletti,X., Rousseau,B., Alberts,S., Aparicio,T., Boukovinas,I., Gill,S., Goldberg,R. M., Grothey,A., Hamaguchi,T., Iveson,T., Kerr,R., Labianca,R., Lonardi Sara, Meyerhardt,J., Paul,J. (…)European Journal of Cancer
Health outcomes and direct healthcare costs in patients with Melanoma: Associations with level of educationBuja,A., Rivera,M., Zorzi,M., Sperotto,M., Baracco,S., Italiano,I., Vecchiato Antonella, Del Fiore Santo Paolo, Avossa,F., Corti,M. C., Guzzinati,S., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoActa Dermato-Venereologica
Health status of female Moldovan migrants to Italy by health literacy level and age group: a descriptive studyVianello,F. A., Zaccagnini,F., Pinato Carlo, Maculan,P., Buja,A.BMC Public Health
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino studyRaimondi,A., Di Maio,M., Morano,F., Corallo,S., Lonardi Sara, Antoniotti,C., Rimassa,L., Sartore-Bianchi,A., Tampellini,M., Ritorto,G., Murialdo,R., Clavarezza,M., Zaniboni,A., Adamo,V., Tomasello,G., Petrelli,F., Antonuzzo,L., Giordano,M., Cinieri,S., Longarini,R. (…)European Journal of Cancer
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITACodolo,G., Toffoletto,M., Chemello,F., Coletta,S., Soler Teixidor,G., Battaggia,G., Munari Giada, Fassan,M., Cagnin,S., de Bernard,M.Frontiers in immunology
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisSchettini,F., Pascual,T., Conte,B., Chic,N., Brasó-Maristany,F., Galvàn,P., Martìnez,O., Adamo,B., Vidal,M., Muñoz,M., Fernàndez-Martinez,A., Rognoni,C., Griguolo Gaia, Guarneri Valentina, Conte PierFranco, Locci,M., Brase,J. C., Gonzalez-Farre,B., Villagrasa,P., De Placido,S. (…)Cancer treatment reviews
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR studyGacci,M., Artibani,W., Bassi,P., Bertoni,F., Bracarda,S., Briganti,A., Carmignani,G., Carmignani,L., Conti,G., Corvò,R., De Nunzio,C., Fusco,F., Graziotti,P., Greco,I., Maggi,S., Magrini,S. M., Mirone,V., Montironi,R., Morgia,G., Muto,G. (…)World journal of urology
Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donorsMagri,S., Masetto Elena, Solito,S., Francescato,S., Belluzzi,E., Pozzuoli,A., Berizzi,A., Ruggieri,P., Mandruzzato SusannaImmunity & Ageing
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literatureVisentin,A., Imbergamo,S., Trimarco,V., Pravato,S., Romano Gargarella,L., Frezzato,F., Scapinello,G., Bertorelle Roberta, Piva,E., Facco,M., Semenzato,G., Piazza,F., Trentin,L.HEMATOLOGICAL ONCOLOGY
Identification of host variants associated with overall survival of esophageal cancer patients receiving platinum-based therapyRumiato,E., Boldrin Elisa, Malacrida,S., Battaglia,G., Chiarion-Sileni Vanna, Ruol,A., Amadori Alberto, Saggioro DanielaPharmacogenomics
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysisBarilà ,G., Bonaldi Laura, Grassi Angela, Martines Annalisa, Lico,A., Macrì,N., Nalio Silvia, Pavan,L., Berno,T., Branca,A., Calabretto,G., Carrino,M., Teramo,A., Manni,S., Piazza,F., Semenzato,G., Zambello,R.Blood Cancer Journal
Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete responseKotsafti Andromachi, Scarpa Melania, Cavallin,F., Fassan,M., Salmaso,R., Porzionato,A., Saadeh,L., Cagol BREAST UNIT Matteo, Alfieri Rita, Castoro,C., Rugge,M., Castagliuolo,I., Scarpa,M.Oncoimmunology
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapyCecchin,E., De Mattia,E., Dreussi,E., Montico,M., Palazzari,E., Navarria,F., Bergamo Francesca, Belluco,C., Quartuccio,L., De Vita,S., Canzonieri,V., Gagno,S., Zanusso,C., Buonadonna,A., Pucciarelli,S., De Paoli,A., Toffoli,G.Radiotherapy and Oncology
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancerArai,H., Xiao,Y., Loupakis Fotios, Kawanishi,N., Wang,J., Battaglin,F., Soni,S., Zhang,W., Mancao,C., Salhia,B., Mumenthaler,S. M., Weisenberger,D. J., Liang,G., Cremolini,C., Falcone,A., Millstein,J., Lenz,H. -JJournal for immunotherapy of cancer
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfallPezzuto,F., Fortarezza,F., Mammana,M., Pasello Giulia, Pelosi,G., Rea,F., Calabrese,F.Histopathology
Impact of Age on Short- And Long-Term Outcomes after Pancreatoduodenectomy for Periampullary NeoplasmsGruppo Mario, Tolin Francesca , Franzato Boris, Pilati Pierluigi, Spolverato,Y. C., Zingales,F., Angriman,I., Bardini,R.Gastroenterology Research and Practice
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenibCasadei-Gardini,A., Rovesti,G., Dadduzio Vincenzo, Vivaldi,C., Lai,E., Lonardi Sara, Fornaro,L., Pretta,A., Zagonel Vittorina, Bernardini,L., Astara,G., D’Amico,F. E., Masi,G., Rimini,M., Scartozzi,M., Cascinu,S.HPB : the official journal of the International Hepato Pancreato Biliary Association
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologistsOttaviano,M., Curvietto,M., Rescigno,P., Tortora,M., Palmieri,G., Giannarelli,D., Aieta,M., Assalone,P., Attademo,L., Avallone,A., Bloise,F., Bosso,D., Borzillo,V., Buono,G., Calderoni,G., Caputo,F., Cartenì,G., Cavallero,D., Cavo,A., Ciardiello,F. (…)Journal for immunotherapy of cancer
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance StudyMalapelle,U., Parente,P., Pepe,F., De Luca,C., Cerino,P., Covelli,C., Balestrieri,M., Russo,G., Bonfitto,A., Pisapia,P., Fiordelisi,F., D’Armiento,M., Bruzzese,D., Loupakis Fotios, Pietrantonio,F., Triassi,M., Fassan,M., Troncone,G., Graziano,P.Cells
Impact of the COVID-19 pandemic on urological practice in emergency departments in ItalyNovara,G., Bartoletti,R., CRESTANI ALESSANDRO, De Nunzio,C., Durante,J., Gregori,A., Liguori,G., Pavan,N., Trombetta,C., Simonato,A., Tubaro,A., Ficarra,V., Porpiglia,F., members of the Research Urology Network (RUN) (seeBJU international
Implications of metabolism-driven myeloid dysfunctions in cancer therapyStrauss,L., Guarneri Valentina, Gennari,A., Sica,A.Cellular and Molecular Immunology
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology ApproachPiga Ilaria, Verza,M., Montenegro,F., Nardo Giorgia, Zulato Elisabetta, Zanin Tiziana, Del Bianco Paola, Esposito Giovanni, Indraccolo StefanoFrontiers in Oncology
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancerCaffo,O., Gasparro,D., Di Lorenzo,G., Volta,A. D., Guglielmini,P., Zucali,P., Bortolus,R., Cavo,A., Ceresoli,G., Chiari,R., Fornarini,G., Fratino,L., Iaculli,A., Maruzzo Marco, Masini,C., Morelli,F., Mucciarini,C., Procopio,G., Sabbatini,R., Verri,E. (…)European Journal of Cancer
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in ItalyAschele,C., Negru,M. E., Pastorino,A., Cavanna,L., Zagonel Vittorina, Barone-Adesi,F., Blasi,L.JAMA ONCOLOGY
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)Casanova,M., Brennan,B., Alaggio,R., Kelsey,A., Orbach,D., van Noesel,M. M., Corradini,N., Minard-Colin,V., Zanetti,I., Bisogno,G., Gallego,S., Merks,J. H. M., De Salvo Gian Luca, Ferrari,A.European Journal of Cancer
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trialGennari,A., Foca,F., Zamarchi Rita, Rocca,A., Amadori,D., De Censi,A., Bologna,A., Cavanna,L., Gianni,L., Scaltriti,L., Rossi Elisabetta, Facchinetti Antonella, Martini,V., Bruzzi,P., Nanni,O.Breast cancer research and treatment
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapyDieci Maria Vittoria, Tsvetkova,V., Griguolo Gaia, Miglietta,F., Tasca Giulia, Giorgi Carlo Alberto, Cumerlato,E., Massa,D., Lo Mele,M., Orvieto,E., Guarneri Valentina, Conte PierFrancoEuropean Journal of Cancer
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasisSchlicker,A., Ellappalayam,A., Beumer,I. J., Snel,M. H. J., Mittempergher,L., Diosdado,B., Dreezen,C., Tian,S., Salazar,R., Loupakis Fotios, Pietrantonio,F., Santos Vivas,C., Martinez-Villacampa,M. M., Villanueva,A., Sanjuàn,X., Schirripa Marta, Fassan,M., Martinetti,A., Fucà ,G., Lonardi Sara (…)International Journal of Cancer
Is burnout affecting life satisfaction in oncologists? The moderating role of family concerns in an Italian sampleCheli,S., Zagonel Vittorina, Oliani,C., Blasi,L., Fioretto,L.Psycho-oncology
Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersocieties (SINch/AINO/SIN) documentRudà,R., Angileri,F. F., Ius,T., Silvani,A., Sarubbo,S., Solari,A., Castellano,A., Falini,A., Pollo,B., Del Basso De Caro,M., Papagno,C., Minniti,G., De Paula,U., Navarria,P., Nicolato,A., Salmaggi,A., Pace,A., Fabi,A., Caffo,M., Lombardi Giuseppe (…)Journal of neurosurgical sciences
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trialBarni,S., Rosati,G., Lonardi Sara, Pella,N., Banzi,M., Zampino,M. G., Dotti,K. F., Rimassa,L., Marchetti,P., Maiello,E., Artioli,F., Ferrari,D., Labianca,R., Bidoli,P., Zaniboni,A., Sobrero,A., Iaffaioli,V., De Placido,S., Frassineti,G. L., Ciarlo,A. (…)Therapeutic advances in medical oncology
Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traitsMoserle Lidia, Pons,R., Martínez-Lozano,M., Jiménez-Valerio,G. A., Vidal,A., Suárez,C., Trilla,E., Jiménez,J., de Torres,I., Carles,J., Senserrich,J., Aguilar,S., Palomero,L., Amadori Alberto, Casanovas,O.EMBO molecular medicine
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target PopulationSchirripa Marta, Nappo,F., Cremolini,C., Salvatore,L., Rossini,D., Bensi,M., Businello,G., Pietrantonio,F., Randon,G., Fucà ,G., Boccaccino,A., Bergamo Francesca, Lonardi Sara, Dei Tos,A. P., Fassan,M., Loupakis FotiosClinical Colorectal Cancer
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: Design and biological in vitro dataBrustolin,L., Pettenuzzo,N., Nardon,C., Quarta,S., Montagner Monia Isabella, Pontisso,P., Rosato Antonio, Conte PierFranco, Merigliano,S., Fregona,D.JOURNAL OF INORGANIC BIOCHEMISTRY
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registryArjona-Sanchez,A., Aziz,O., Passot,G., Salti,G., Esquivel,J., Van der Speeten,K., Piso,P., Nedeclut,S., Sommariva Antonio, Yonemura,Y., Turaga,K., Selvasekar,C. R., Rodriguez-Ortiz,L., Sanchez-Hidalgo,J. M., Casado-Adam,A., Rufian-Peña,S., Briceño,J., Glehen,O.European Journal of Surgical Oncology
Laparoscopic hyperthermic intraperitoneal chemotherapy for appendiceal tumorsSommariva Antonio, Tonello Marco, De Simoni,O., Barina,A., Rossi Carlo Riccardo, Pilati PierluigiAsian journal of endoscopic surgery
Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional StudyMarkar,S. R., Zaninotto,G., Castoro,C., Johar,A., Lagergren,P., Elliott,J. A., Gisbertz,S. S., Mariette,C., Alfieri Rita, Huddy,J., Sounderajah,V., Pinto Eleonora, Scarpa,M., Klevebro,F., Sunde,B., Murphy,C. F., Greene,C., Ravi,N., Piessen,G., Brenkman,H. (…)Annals of surgery
Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancyMariscotti,G., Durando,M., Ruggirello,I., Belli,P., Caumo Francesca, Nori,J., Zuiani,C., Tagliafico,A., Bicchierai,G., Romanucci,G., Londero,V., Campanino,P. P., Bussone,R., Castellano,I., Mule,A., Caneva,A., Bianchi,S., Di Loreto,C., Bergamasco,L., Calabrese,M. (…)European Journal of Radiology
Limiting treatment plan complexity by applying a novel commercial toolScaggion Alessandro, Fusella Marco, Agnello,G., Bettinelli Andrea, Pivato,N., Roggio Antonella, Rossato Marco Andrea, Sepulcri Matteo, Paiusco MartaJournal of applied clinical medical physics
Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases ComparedRossi Elisabetta, Zin,A., Facchinetti Antonella, Poggiana,C., Tombolan,L., Affinita,M. C., Bonvini,P., Santoro,L., Schiavi Francesca, Bisogno,G., Zamarchi RitaDiagnostics (Basel)
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trialVernieri,C., Ganzinelli,M., Rulli,E., Farina,G., Bettini,A. C., Bareggi,C., Rosso,L., Signorelli,D., Galli,G., Lo Russo,G., Proto,C., Moro,M., Indraccolo Stefano, Busico,A., Sozzi,G., Torri,V., Marabese,M., Massimo,B., Garassino,M. C., TAILOR trialists (…)ESMO Open
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 studyTerwisscha van Scheltinga,S. E. J., Wijnen,M. H. W. A., Martelli,H., Rogers,T., Mandeville,H., Gaze,M. N., McHugh,K., Corradini,N., Orbach,D., Jenney,M., Kelsey,A., Chisholm,J., Gallego,S., Glosli,H., Ferrari,A., Zanetti,I., De Salvo Gian Luca, Minard-Colin,V., Bisogno,G., van Noesel,M. M. (…)Cancer Medicine
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialVaidya,J. S., Bulsara,M., Baum,M., Wenz,F., Massarut,S., Pigorsch,S., Alvarado,M., Douek,M., Saunders,C., Flyger,H. L., Eiermann,W., Brew-Graves,C., Williams,N. R., Potyka,I., Roberts,N., Bernstein,M., Brown,D., Sperk,E., Laws,S., Sütterlin,M. (…)British Medical Journal – BMJ
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literatureLizzul,L., Lombardi Giuseppe, Barbot,M., Ceccato,F., Gardiman,M. P., Regazzo,D., Bellu,L., Mazza,E., Losa,M., Scaroni,C.Pituitary
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal CancerTosi,F., Sartore-Bianchi,A., Lonardi Sara, Amatu,A., Leone,F., Ghezzi,S., Martino,C., Bencardino,K., Bonazzina,E., Bergamo Francesca, Fenocchio,E., Martinelli,E., Troiani,T., Siravegna,G., Mauri,G., Torri,V., Marrapese,G., Valtorta,E., Cassingena,A., Cappello,G. (…)Clinical Colorectal Cancer
Long-term clinical, virological and immunological outcomes following planned treatment interruption in HIV-infected childrenFreguja,R., Bamford,A., Zanchetta Marisa, Del Bianco Paola, Giaquinto,C., Harper,L., Dalzini,A., Cressey,T. R., Compagnucci,A., Saidi,Y., Riault,Y., Ford,D., Gibb,D., Klein,N., De Rossi Anita, Paediatric European Network for Treatment of AIDSHIV Medicine
Long-term outcomes of induction chemotherapy followed by chemo-radiotherapy as intensive neoadjuvant protocol in patients with esophageal cancer Simoni,N., Pavarana,M., Micera,R., Weindelmayer,J., Mengardo,V., Rossi,G., Cenzi,D., Tomezzoli,A., Del Bianco Paola, Giacopuzzi,S., De Manzoni,G., Mazzarotto,R.Cancers
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerD’Alimonte,L., Bao,Q. R., Spolverato,G., Capelli,G., Del Bianco Paola, Albertoni,L., De Paoli,A., Guerrieri,M., Mantello,G., Gambacorta,M. A., Canzonieri,V., Valentini,V., Coco,C., Pucciarelli,S.Annals of Surgical Oncology
Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatmentMandruzzato Susanna, Pinton Laura, Masetto Elena, Vettore,M., Bonaudo,C., Lombardi Giuseppe, Della Puppa,A.Neuro-oncology advances
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for TreatmentFrega Stefano, Ferro,A., Bonanno Laura, Guarneri Valentina, Conte PierFranco, Pasello GiuliaInternational Journal of Molecular Sciences
Macular Perfusion Impairment in Von Hippel-Lindau Disease Suggests a Generalized Retinal Vessel AlterationPilotto,E., Nacci,E. B., Ferrara Alfonso Massimiliano, De Mojà ,G., Zovato Stefania, Midena,E.Journal of clinical medicine
Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelinesSbrana,A., Antonuzzo,A., Brunello Antonella, Petrelli,F., Pronzato,P., Tralongo,A., Turrini,M., Zoratto,F., Danova,M.Tumori Journal
Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centersNappi,L., Ottaviano,M., Rescigno,P., Tortora,M., Banna,G. L., Baciarello,G., Basso Umberto, Canil,C., Cavo,A., Rocca,M. C., Czaykowski,P., De Giorgi,U., Del Muro,X. G., Di Napoli,M., Fornarini,G., Gietema,J. A., Heng,D. Y. C., Hotte,S. J., Kollmannsberger,C., Maruzzo Marco (…)Oncologist
Mathematical models for HIV treatment : A schematic reviewBuratto,A., Cesaretto,R., Zamarchi RitaJournal of Interdisciplinary Mathematics
MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP projectCaini,S., Gandini,S., Botta,F., Tagliabue,E., Raimondi,S., Nagore,E., Zanna,I., Maisonneuve,P., Newton-Bishop,J., Polsky,D., Lazovich,D., Kumar,R., Kanetsky,P. A., Hoiom,V., Ghiorzo,P., Landi,M. T., Ribas,G., Menin Chiara, Stratigos,A. J., Palmieri,G. (…)Melanoma research
MC1R variants in relation to naevi in melanoma cases and controls: a pooled-analysis from the M-SKIP projectStefanaki,I., Stratigos,A. J., Kypreou,K. P., Evangelou,E., Gandini,S., Maisonneuve,P., Polsky,D., Lazovich,D., Newton-Bishop,J., Kanetsky,P. A., Puig,S., Gruis,N. A., Ghiorzo,P., Pellegrini,C., De Nicolo Arcangela, Ribas,G., Guida,G., Garcia-Borron,J. C., Fargnoli,M. C., Nan,H. (…)Journal of the European Academy of Dermatology and Venereology
Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)Gaviani,P., Simonetti,G., Ruda,R., Franchino,F., Lombardi Giuseppe, Possanzini,M., Squintu,S., Villani,V., Teriaca,M., Cavallieri,F., Caffo,M., Salmaggi,A., Bianco,A., Anghileri,E., Farinotti,M., Tramacere,I., Silvani,A.Neurological Sciences
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysisBhave,P., Pallan,L., Long,G. V., Menzies,A. M., Atkinson,V., Cohen,J. V., Sullivan,R. J., Chiarion-Sileni Vanna, Nyakas,M., Kahler,K., Hauschild,A., Plummer,R., Trojaniello,C., Ascierto,P. A., Zimmer,L., Schadendorf,D., Allayous,C., Lebbe,C., Maurichi,A., Santinami,M. (…)British Journal of Cancer
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensWainberg,Z. A., Feeney,K., Lee,M. A., Munoz,A., Gracian,A. C., Lonardi Sara, Ryoo,B. Y., Hung,A., Lin,Y., Bendell,J., Hecht,J. R.BMC cancer
Metabolism in the Tumor MicroenvironmentMontenegro,F., Indraccolo StefanoAdvances in Experimental Medicine and Biology
Metastases to the thyroid gland: review of incidence, clinical presentation, diagnostic problems and surgery, our experienceBattistella,E., Pomba Luca, Mattara Genny, Franzato Boris, Toniato AntonioJournal of endocrinological investigation
MI NUTRO (Migrants nutrition knowledge for integration): A nutrition education intervention among immigrants, Perugia (Italy) – Pilot studyNucci Daniele, Minelli,L., Gianfredi,V.Recenti progressi in medicina
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant TrialsCohen,R., Taieb,J., Fiskum,J., Yothers,G., Goldberg,R., Yoshino,T., Alberts,S., Allegra,C., de Gramont,A., Seitz,J. F., O’Connell,M., Haller,D., Wolmark,N., Erlichman,C., Zaniboni,A., Lonardi Sara, Kerr,R., Grothey,A., Sinicrope,F. A., André,T. (…)Journal of Clinical Oncology
miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic LeukemiaSaccomani,V., Grassi Angela, Piovan Erich, Bongiovanni,D., Di Martino,L., Minuzzo,S., Tosello Valeria, Zanovello PaolaCells
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancerBarisciano,G., Colangelo,T., Rosato,V., Muccillo,L., Taddei,M. L., Ippolito,L., Chiarugi,P., Galgani,M., Bruzzaniti,S., Matarese,G., Fassan,M., Agostini,M., Bergamo Francesca, Pucciarelli,S., Carbone,A., Mazzoccoli,G., Colantuoni,V., Bianchi,F., Sabatino,L.British Journal of Cancer
Mismatch-repair protein expression in high-grade gliomas: A large retrospective multicenter studyCaccese Mario, Ius,T., Simonelli,M., Fassan,M., Cesselli,D., Dipasquale,A., Cavallin,F., Padovan,M., Salvalaggio,A., Gardiman,M. P., Skrap,M., Zagonel Vittorina, Lombardi GiuseppeInternational Journal of Molecular Sciences
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiencyBarresi,L., Tacelli,M., Crinò. F., Attili,F., Petrone,M. C., De Nucci,G., Carrara,S., Manfredi,G., Capurso,G., De Angelis,C. G., Crocellà ,L., Fantin Alberto, Dore,M. F., Garribba,A. T., Tarantino,I., De Pretis,N., Pagliari,D., Rossi,G., Manes,G., Preatoni,P. (…)United European Gastroenterology Journal
Multifocal Medulloblastoma in an Adult Patient: Description of a Rare Presentation and Review of the LiteratureTroncon,I., Guerriero,A., Rossi,S., Ronzon,M., Padovan,M., Caccese Mario, Zanatta,L., Toffolatti,L., Marton,E., Lombardi Giuseppe, Tos,A. P. D., Canova,G.Case reports in pathology
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretomeCapaci,V., Bascetta,L., Fantuz,M., Beznoussenko,G. V., Sommaggio Roberta, Cancila,V., Bisso,A., Campaner,E., Mironov,A. A., WiÅ›niewski,J. R., Ulloa Severino,L., Scaini,D., Bossi,F., Lees,J., Alon,N., Brunga,L., Malkin,D., Piazza,S., Collavin,L., Rosato Antonio (…)Nature Communications
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemiaOshima,K., Zhao,J., Pérez-Durán,P., Brown,J. A., Patiño-Galindo,J. A., Chu,T., Quinn,A., Gunning,T., Belver,L., Ambesi-Impiombato,A., Tosello Valeria, Wang,Z., Sulis,M. L., Kato,M., Koh,K., Paganin,M., Basso,G., Balbin,M., Nicolas,C., Gastier-Foster,J. M. (…)Nature Cancer
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES StudyPagano,M., Ceresoli,L. G., Zucali,P. A., Pasello Giulia, Garassino,M., Grosso,F., Tiseo,M., Soto Parra,H., Zanelli,F., Cappuzzo,F., Grossi,F., De Marinis,F., Pedrazzoli,P., Gnoni,R., Bonelli,C., Torricelli,F., Ciarrocchi,A., Normanno,N., Pinto,C.Cancers
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint BlockadePeranzoni,E., Ingangi Vincenzo, Masetto Elena, Pinton Laura, Marigo Ilaria Frontiers in immunology
Nanoparticles as tools to target redox homeostasis in cancer cellsCiccarese Francesco, Raimondi Vittoria, Sharova Evgeniya, Silic-Benussi Micol, Ciminale VincenzoAntioxidants
Near infrared photoimmunotherapy targeting the cutaneous lymphocyte antigen for mycosis fungoidesSilic-Benussi Micol, Saponeri,A., Michelotto,A., Russo,I., Colombo,A., Pelizzo,M. G., Ciminale Vincenzo, Alaibac,M.Expert Opinion on Biological Therapy
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma GroupsGronchi,A., Palmerini,E., Quagliuolo,V., Martin Broto,J., Lopez Pousa,A., Grignani,G., Brunello Antonella, Blay,J. Y., Tendero,O., Diaz Beveridge,R., Ferraresi,V., Lugowska,I., Merlo,D. F., Fontana,V., Marchesi,E., Braglia,L., Donati,D. M., Palassini,E., Bianchi,G., Marrari,A. (…)Journal of Clinical Oncology
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: A multi-cycle, phase II studyCaputo,R., Cazzaniga,M. E., Sbrana,A., Torrisi,R., Paris,I., Giordano,M., Montesarchio,V., Guarneri Valentina, Amaducci,L., Bilancia,D., Cilenti,G., Fabi,A., Collovà,E., Schirone,A., Bonizzoni,E., Celio,L., De Placido,S., De Laurentiis,M.BMC cancer
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyCaputo,R., Cazzaniga,M. E., Sbrana,A., Torrisi,R., Paris,I., Giordano,M., Montesarchio,V., Guarneri Valentina, Amaducci,L., Bilancia,D., Cilenti,G., Fabi,A., Collovà,E., Schirone,A., Bonizzoni,E., Celio,L., De Placido,S., De Laurentiis,M.BMC cancer
Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian CrisisSimonelli,M., Franceschi,E., Lombardi GiuseppeFrontiers in Medicine
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapyBanna,G. L., Di Quattro,R., Malatino,L., Fornarini,G., Addeo,A., Maruzzo Marco, Urzia,V., Rundo,F., Lipari,H., De Giorgi,U., Basso UmbertoClinical & Translational Oncology
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupRacanelli,D., Brenca,M., Baldazzi,D., Goeman,F., Casini,B., De Angelis,B., Guercio,M., Milano,G. M., Tamborini,E., Busico,A., Dagrada,G., Garofalo Cecilia, Caruso Chiara, Brunello Antonella, Pignochino,Y., Berrino,E., Grignani,G., Scotlandi,K., Parra,A., Hattinger,C. M. (…)Frontiers in Oncology
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series StudyVianello,A., Salton,F., Molena,B., Turato Cristian, Graziani,M. L., Braccioni,F., Frassani,V., Sella,D., Pretto,P., Paladini,L., Sukthi,A., Confalonieri,M.Journal of clinical medicine
Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM)Capelli,G., De Simone,I., Spolverato,G., Cinquini,M., Moschetti,I., Lonardi Sara, Masi,G., Carlomagno,C., Corsi,D., Luppi,G., Gambacorta,M. A., Valvo,F., Cannizzaro,R., Grillo,F., Barbaro,B., Restivo,A., Messina,M., Pastorino,A., Aschele,C., Pucciarelli,S. (…)Journal of Gastrointestinal Surgery
Novel nuclear medicine imaging applications in immuno-oncologyFrega Stefano, Maso,A. D., Pasello Giulia, Cuppari,L., Bonanno Laura, Conte PierFranco, Evangelista,L.Cancers
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety StudyParrozzani,R., Lombardi Giuseppe, Midena,E., Londei,D., Padovan,M., Marchione,G., Caccese Mario, Midena,G., Zagonel Vittorina, Frizziero,L.Frontiers in Oncology
Oesophageal perforation due to difficult intubation: our experience and review of literatureBattistella,E., Pomba Luca, Merigliano,S., Toniato AntonioMinerva chirurgica
Olaparib for advanced breast cancerGriguolo Gaia, Dieci Maria Vittoria, Miglietta,F., Guarneri Valentina, Conte PierFrancoFuture Oncology
Older cancer patients and COVID-19 outbreak: Practical considerations and recommendationsBrunello Antonella, Galiano Antonella, Finotto Silvia, Monfardini,S., Colloca,G., Balducci,L., Zagonel VittorinaCancer Medicine
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord OvestMoretto,R., Rossini,D., Zucchelli,G., Lonardi Sara, Bergamo Francesca, Santini,D., Cupini,S., Tomasello,G., Caponnetto,S., Zaniboni,A., Antoniotti,C., Pietrantonio,F., Buonadonna,A., Marmorino,F., Bordonaro,R., Fea,E., Tamburini,E., Boccaccino,A., Grande,R., Aprile,G. (…)European Journal of Cancer
Oligometastatic pancreatic cancer to the liver in the era of neoadjuvant chemotherapy: Which role for conversion surgery? A systematic review and meta-analysisDe Simoni,O., Scarpa,M., Tonello Marco, Pilati Pierluigi, Tolin Francesca , Spolverato,Y., Gruppo MarioCancers
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2Caffo,O., Zagonel Vittorina, Baldessari,C., Berruti,A., Bortolus,R., Buti,S., Ceresoli,G. L., Donini,M., Ermacora,P., Fornarini,G., Fratino,L., Masini,C., Massari,F., Mosca,A., Mucciarini,C., Procopio,G., Tucci,M., Verri,E., Zucali,P., Buttigliero,C. (…)Annals of Oncology
Oncological care organisation during COVID-19 outbreakOnesti,C. E., Rugo,H. S., Generali,D., Peeters,M., Zaman,K., Wildiers,H., Harbeck,N., Martin,M., Cristofanilli,M., Cortes,J., Tjan-Heijnen,V., Hurvitz,S. A., Berchem,G., Tagliamento,M., Campone,M., Bartsch,R., De Placido,S., Puglisi,F., Rottey,S., Muller,V. (…)ESMO Open
Oncological outcome of videoscopic groin dissection for lymph node metastasis from melanomaSommariva Antonio, Cona,C., Tonello Marco, Pilati Pierluigi, Rossi Carlo RiccardoSurgical Endoscopy and Other Interventional Techniques
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung CancerWu,Y. L., Tsuboi,M., He,J., John,T., Grohe,C., Majem,M., Goldman,J. W., Laktionov,K., Kim,S. W., Kato,T., Vu,H. V., Lu,S., Lee,K. Y., Akewanlop,C., Yu,C. J., de Marinis,F., Bonanno Laura, Domine,M., Shepherd,F. A., Zeng,L. (…)The New England Journal of Medicine
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysisMammana,M., Bergamo Francesca, Procaccio,L., Schiavon,M., Loupakis Fotios, Lonardi Sara, Manai Chiara, Schirripa Marta, Fassan,M., Dei Tos,A. P., Calabrese,F., Rea,F., Zagonel VittorinaTumori Journal
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyFerrari,A., Merks,J. H. M., Chisholm,J. C., Orbach,D., Brennan,B., Gallego,S., van Noesel,M. M., McHugh,K., van Rijn,R. R., Gaze,M. N., Martelli,H., Bergeron,C., Corradini,N., Minard-Colin,V., Bisogno,G., Geoerger,B., Caron,H. N., De Salvo Gian Luca, Casanova,M.European Journal of Cancer
Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: A matched cohort analysis from the InspECT registrySersa,G., Mascherini,M., Di Prata,C., Odili,J., de Terlizzi,F., McKenzie,G. A. G., Clover,A. J. P., Bertino,G., Spina Romina, Groselj,A., Cappellesso,R., Gehl,J., Bisase,B., Curatolo,P., Kis,E., Lico,V., Muir,T., Orlando,A., Quaglino,P., Matteucci,P. (…)European Journal of Surgical Oncology
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanomaAscierto,P. A., Del Vecchio,M., Mackiewicz,A., Robert,C., Chiarion-Sileni Vanna, Arance,A., Lebbé,C., Svane,I. M., Mcneil,C., Rutkowski,P., Loquai,C., Mortier,L., Hamid,O., Bastholt,L., Dreno,B., Schadendorf,D., Garbe,C., Nyakas,M., Grob,J. -J, Thomas,L. (…)Journal for immunotherapy of cancer
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO StudyLa Verde,N., Collovà ,E., Blasi,L., Pinotti,G., Palumbo,R., Bonotto,M., Garrone,O., Brunello Antonella, Rimanti,A., Bareggi,C., Zaniboni,A., Frassoldati,A., Foglietta,J., Berardi,R., Moretti,A., Farina,G., Porcu,L., Barni,S.Clinical breast cancer
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysisSchettini,F., Giudici,F., Giuliano,M., Cristofanilli,M., Arpino,G., Del Mastro,L., Puglisi,F., De Placido,S., Paris,I., De Placido,P., Venturini,S., De Laurentis,M., Conte PierFranco, Juric,D., Llombart-Cussac,A., Pusztai,L., Prat,A., Jerusalem,G., Di Leo,A., Generali,D. (…)Journal of the National Cancer Institute
Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA Phase 3 Randomized TrialPetrelli,F., Rulli,E., Labianca,R., Lonardi Sara, Rosati,G., Dotti,K., Ronzoni,M., Pella,N., Pusceddu,V., Banzi,M., Zampino,M. G., Yasmina,M., Marchetti,P., Cantore,M., Zaniboni,A., Rimassa,L., Ciuffreda,L., Ferrari,D., Zagonel Vittorina, Maiello,E. (…)Annals of Oncology
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)Antonelli,A., Palumbo,C., Noale,M., Artibani,W., Bassi,P., Bertoni,F., Bracarda,S., Bruni,A., Corvò,R., Gacci,M., Magrini,S. M., Montironi,R., Porreca,A., Tubaro,A., Zagonel Vittorina, Maggi,S., and the Pros-IT CNR study groupMinerva urologica e nefrologica
p16/ki67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive womenRossi,P. G., Carozzi,F., Ronco,G., Allia,E., Bisanzi,S., Gillio-Tos,A., De Marco,L., Rizzolo,R., Gustinucci,D., Del Mistro Annarosa, Frayle – Salamanca Helena, Confortini,M., Iossa,A., Cesarini,E., Bulletti,S., Passamonti,B., GORI SILVIA, Toniolo,L., Barca,A., Bonvicini,L. (…)Journal of the National Cancer Institute
Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG)Rogers,T. N., De Corti,F., Burrieza,G. G., Guérin,F., Terwisscha van Scheltinga,S., Smeulders,N., Craigie,R., Jenney,M., Kelsey,A., Zanetti,I., Coppadoro,B., De Salvo Gian Luca, Bisogno,G., Martelli,H.Pediatric Blood & Cancer
Parathyroidectomy Resolves Tooth Discoloration: A New Presenting Sign of Hyperparathyroidism?Musacchio,E., Piotto,A., Binotto,P., Toniato Antonio, Sartori,L.Case Reports in Dentistry
Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastasesBaratti,D., Sammartino,P., Kusamura,S., Deraco,M., Peritoneal Surface Malignancy Onco-team of the Ita, Ansaloni,L., Asero,S., Baiocchi,G., Bagnoli,P., Cavaliere,D., Framarini,M., Cirocchi,R., Coccolini,F., Decian,F., Delrio,P., Sassaroli,C., De Simone,M., Robella,M., Vaira,M., Di Giorgio,A. (…)European Journal of Surgical Oncology
Patient-derived scaffolds of colorectal cancer metastases as an organotypic 3D model of the liver metastatic microenvironmentD’angelo,E., Natarajan,D., Sensi,F., Ajayi,O., Fassan,M., Mammano E, Pilati Pierluigi, Pavan,P., Bresolin,S., Preziosi,M., Miquel,R., Zen,Y., Chokshi,S., Menon,K., Heaton,N., Spolverato,G., Piccoli,M., Williams,R., Urbani,L., Agostini,M. (…)Cancers
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancerConte PierFranco, Schneeweiss,A., Loibl,S., Mamounas,E. P., von Minckwitz,G., Mano,M. S., Untch,M., Huang,C. S., Wolmark,N., Rastogi,P., D’Hondt,V., Redondo,A., Stamatovic,L., Bonnefoi,H., Castro-Salguero,H., Fischer,H. H., Wahl,T., Song,C., Boulet,T., Trask,P. (…)Cancer
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent mannerTombolan,L., Rossi Elisabetta, Zin,A., Santoro,L., Bonvini,P., Zamarchi Rita, Bisogno,G.Translational oncology
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot StudyLombardi Giuseppe, Barresi,V., Indraccolo Stefano, Simbolo,M., Fassan,M., Mandruzzato Susanna, Simonelli,M., Caccese Mario, Pizzi,M., Fassina,A., Padovan,M., Masetto Elena, Gardiman,M. P., Bonavina Maria Giuseppina, Caffo,M., Persico,P., Chioffi,F., Denaro,L., Dei Tos,A. P., Scarpa,A. (…)Cancers
Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic SarcomaPiano Maria Assunta, Brunello Antonella, Cappellesso,R., Del Bianco Paola, Mattiolo,A., Fritegotto Chiara, Montini,B., Zamuner Diagnostica Melanomi Sarcomi Carolina, Del Fiore Santo Paolo, Rastrelli Marco, Sommariva Antonio, De Salvo Gian Luca, Montesco Maria Cristina, Rossi Carlo Riccardo, Zagonel Vittorina, Calabrò Maria LuisaClinical Cancer Research
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trialSartore-Bianchi,A., Lonardi Sara, Martino,C., Fenocchio,E., Tosi,F., Ghezzi,S., Leone,F., Bergamo Francesca, Zagonel Vittorina, Ciardiello,F., Ardizzoni,A., Amatu,A., Bencardino,K., Valtorta,E., Grassi,E., Torri,V., Bonoldi,E., Sapino,A., Vanzulli,A., Regge,D. (…)ESMO Open
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma TherapiesCaruso Chiara, Garofalo CeciliaFrontiers in Oncology
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)Damato,A., Iachetta,F., Antonuzzo,L., Nasti,G., Bergamo Francesca, Bordonaro,R., Maiello,E., Zaniboni,A., Tonini,G., Romagnani,A., Berselli,A., Normanno,N., Pinto,C.BMC cancer
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100Moehler,M., Dvorkin,M., Boku,N., Özgüro?lu,M., Ryu,M. H., Muntean,A. S., Lonardi Sara, Nechaeva,M., Bragagnoli,A. C., CoÅŸkun,H. S., Cubillo Gracian,A., Takano,T., Wong,R., Safran,H., Vaccaro,G. M., Wainberg,Z. A., Silver,M. R., Xiong,H., Hong,J., Taieb,J. (…)Journal of Clinical Oncology
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockadeBrasó-Maristany,F., Griguolo Gaia, Pascual,T., Paré ,L., Nuciforo,P., Llombart-Cussac,A., Bermejo,B., Oliveira,M., Morales,S., Martì­nez,N., Vidal,M., Adamo,B., Martìnez,O., Pernas,S., Lòpez,R., Muñoz,M., Chic,N., Galvàn,P., Garau,I., Manso,L. (…)Nature Communications
Pheochromocytomas and paragangliomas in children: Data from the Italian Cooperative Study (TREP)Virgone,C., Andreetta,M., Avanzini,S., Chiaravalli,S., De Pasquale,D., Crocoli,A., Inserra,A., D’Angelo,P., Alaggio,R., Opocher Giuseppe, Cecchetto,G., Ferrari,A., Bisogno,G., Dall’Igna,P.Pediatric Blood & Cancer
Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker AnalysisIndraccolo Stefano, De Salvo Gian Luca, Verza,M., Caccese Mario, Esposito Giovanni, Piga,I., Del Bianco Paola, Pizzi,M., Gardiman,M. P., Eoli,M., Rudà ,R., Brandes,A. A., Ibrahim,T., Rizzato,S., Lolli,I., Zagonel Vittorina, Lombardi GiuseppeClinical Cancer Research
PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtypeGuarneri Valentina, Dieci Maria Vittoria, Bisagni,G., Brandes,A. A., Frassoldati,A., Cavanna,L., Musolino,A., Giotta,F., Rimanti,A., Garrone,O., Bertone,E., Cagossi,K., Nanni,O., Piacentini,F., Orvieto,E., Griguolo Gaia, Curtarello Matteo, Urso,L., Parè,L., Chic,N. (…)Clinical Cancer Research
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerKos,Z., Roblin,E., Kim,R. S., Michiels,S., Gallas,B. D., Chen,W., van de Vijver,K. K., Goel,S., Adams,S., Demaria,S., Viale,G., Nielsen,T. O., Badve,S. S., Symmans,W. F., Sotiriou,C., Rimm,D. L., Hewitt,S., Denkert,C., Loibl,S., Luen,S. J. (…)NPJ breast cancer
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic CancerMerz,V., Zecchetto,C., Santoro,R., Simionato,F., Sabbadini,F., Mangiameli,D., Piro,G., Cavaliere,A., Deiana,M., Valenti,M. T., Bazan,D., Fedele,V., Lonardi Sara, Melisi,D.Clinical Cancer Research
Poly(L-glutamic acid)-co-poly(ethylene glycol) block copolymers for protein conjugationMaso,K., Grigoletto,A., Raccagni,L., Bellini,M., Marigo Ilaria , Ingangi Vincenzo, Suzuki,A., Hirai,M., Kamiya,M., Yoshioka,H., Pasut,G.Journal of Controlled Release
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsBarnes,D. R., Rookus,M. A., McGuffog,L., Leslie,G., Mooij,T. M., Dennis,J., Mavaddat,N., Adlard,J., Ahmed,M., Aittomäki,K., Andrieu,N., Andrulis,I. L., Arnold,N., Arun,B. K., Azzollini,J., Balmaña,J., Barkardottir,R. B., Barrowdale,D., Benitez,J., Berthet,P. (…)Genetics in Medicine
Polymorphisms within immune regulatory pathways predict cetuximab efficacy and survival in metastatic colorectal cancer patientsVolz,N. B., Hanna,D. L., Stintzing,S., Zhang,W., Yang,D., Cao,S., Ning,Y., Matsusaka,S., Sunakawa,Y., Berger,M. D., Cremolini,C., Loupakis Fotios, Falcone,A., Lenz,H. -JCancers
Possible role of circulating tumor cells in early detection of lung cancerPoggiana Cristina, Rossi Elisabetta, Zamarchi RitaJournal of Thoracic Disease
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718QSong,Y., Jia,Z., Wang,Y., Wang,Y., Liu,P., Zhang,S., Bing,Z., Cao,L., Cao,Z., Rossi Elisabetta, Zamarchi Rita, Denis,M. G., Camps,C., Fernandez-Diaz,A., Liang,N., Li,S.Journal of Thoracic Disease
Practical considerations in the use of regorafenib in metastatic colorectal cancerLoupakis Fotios, Antonuzzo,L., Bachet,J. -B, Kuan,F. -C, Macarulla,T., Pietrantonio,F., Xu,R. -H, Taniguchi,H., Winder,T., Yuki,S., Zeng,S., Bekaii-Saab,T.Therapeutic advances in medical oncology
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?Gusella,M., Pasini,F., Corso,B., Bertolaso,L., De Rosa,G., Falci Cristina, Modena,Y., Barile,C., Da Corte,Z. D., Fraccon,A., Toso,S., Cretella,E., Brunello Antonella, Modonesi,C., Segati,R., Oliani,C., Minicuci,N., Padrini,R., Italian TAM GroupPharmacology Research & Perspectives
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesLoupakis Fotios, Depretis Ilaria, Biason Paola, Intini,R., Prete Alessandra Anna, Leone,F., Lombardi,P., Filippi,R., Spallanzani,A., Cascinu,S., Bonetti,L. R., Maddalena,G., Valeri,N., Sottoriva,A., Zapata,L., Salmaso,R., Munari Giada, Rugge,M., Dei Tos,A. P., Golovato,J. (…)Oncologist
Predictive classifier for intensive treatment of head and neck cancerZakeri,K., Rotolo,F., Lacas,B., Vitzthum,L. K., Le,Q. T., Gregoire,V., Overgaard,J., Hackshaw,A., Zackrisson,B., Parmar,M. K. B., Burtness,B. A., Ghi Maria Grazia, Sanguineti,G., O’Sullivan,B., Fortpied,C., Bourhis,J., Shen,H., Harris,J., Michiels,S., Pignon,J. P. (…)Cancer
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup AnalysisRosati,G., Galli,F., Cantore,M., Bergamo Francesca, Banzi,M., Zampino,M. G., Mattioli,R., Cardellino,G. G., Ronzoni,M., Di Bartolomeo,M., Tamberi,S., Marchetti,P., Rimassa,L., Corsi,D., Bochicchio,A. M., Artioli,F., Labianca,R., Galli,F., Rulli,E., Bilancia,D. (…)Oncologist
Pregnancy After Breast Cancer in Patients With Germline BRCA MutationsLambertini,M., Ameye,L., Hamy,A. S., Zingarello,A., Poorvu,P. D., Carrasco,E., Grinshpun,A., Han,S., Rousset-Jablonski,C., Ferrari,A., Paluch-Shimon,S., Cortesi,L., Senechal,C., Miolo,G., Pogoda,K., Pérez-Fidalgo,J. A., De Marchis,L., Ponzone,R., Livraghi,L., Estevez-Diz,M. D. P. (…)Journal of Clinical Oncology
Preliminary dosimetric analysis of DOTA-folate radiopharmaceutical radiolabelled with(47)Sc produced through(nat)V(p,x)(47)Sc cyclotron irradiationDe Nardo,L., Pupillo,G., Mou,L., Furlanetto,D., Rosato Antonio, Esposito,J., Melendez-Alafort LauraPhysics in Medicine and Biology
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialBonvalot,S., Gronchi,A., Le Pèchoux,C., Swallow,C. J., Strauss,D., Meeus,P., van Coevorden,F., Stoldt,S., Stoeckle,E., Rutkowski,P., Rastrelli Marco, Raut,C. P., Hompes,D., De Paoli,A., Sangalli,C., Honoré,C., Chung,P., Miah,A., Blay,J. Y., Fiore,M. (…)Lancet Oncology
Preventing infectious diseases in Intensive Care Unit by medical devices remote control: Lessons from COVID-19Garzotto Francesco, Comoretto,R. I., Ostermann,M., Nalesso,F., Gregori,D., Bonavina Maria Giuseppina, Zanardo Giorgio, Meneghesso,G.Journal of critical care
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive casesDi Liso,E., Bottosso,M., Lo Mele,M., Tsvetkova,V., Dieci Maria Vittoria, MIGLIETTA FEDERICA, Falci Cristina, Faggioni Giovanni, Tasca Giulia, Giorgi Carlo Alberto, Giarratano Tommaso, Mioranza Eleonora, Michieletto Silvia, Saibene Tania, Dei Tos,A. P., Conte PierFranco, Guarneri ValentinaESMO Open
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsMoretto,R., Corallo,S., Belfiore,A., Rossini,D., Boccaccino,A., Lonardi Sara, Centonze,G., Morano,F., Germani,M. M., Loupakis Fotios, Morelli,L., Urbani,L., Brich,S., Marmorino,F., Prisciandaro,M., Aprile,G., Fassan,M., Cillo,U., Cattaneo,L., Fontanini,G. (…)European Journal of Cancer
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaOrsi,G., Tovoli,F., Dadduzio Vincenzo, Vivaldi,C., Brunetti,O., Ielasi,L., Conti,F., Rovesti,G., Gramantieri,L., Rizzato,M. D., Pecora,I., Argentiero,A., Teglia,F., Lonardi Sara, Salani,F., Granito,A., Zagonel Vittorina, Marisi,G., Cabibbo,G., Foschi,F. G. (…)Targeted Oncology
Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinomaAlessandrini,L., Franz,L., Ottaviano,G., Ghi Maria Grazia, Lanza,C., Blandamura,S., Marioni,G.Oral oncology
Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burdenManso,J., Censi,S., Roberti,A., Iacobone,M., Barollo,S., Bertazza,L., Galuppini,F., Vianello Federica, Albinger,N., Scaroni,C., Pennelli,G., Mian,C.Therapeutic Advances in Endocrinology and Metabolism
Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based ApproachCavallari Ilaria, Grassi Angela, Del Bianco Paola, Aceti,A., Zaborra,C., Sharova Evgeniya, Bertazzolo,I., D’Agostino,D. M., Iafrate,M., Ciminale VincenzoCancers
Programmed cell death-1 rs2227981 polymorphism in patients with autoimmune skin blistering disorders: A pilot studyFaina Valentina, Sernicola,A., Russo,I., Michelotto,A., Szathvary,V., Frigo,A. C., Alaibac,M.Meta gene
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field studyKoller,M., Shamieh,O., Hjermstad,M. J., Hornslien,K., Young,T., Chalk,T., Ioannidis,G., Harle,A., Johnson,C. D., Tomaszewski,K. A., Serpentini Samantha, Pinto,M., van der Weijst,L., Janssens,A., Morag,O., Chie,W. C., Arraras,J. I., Pompili,C., Jungraithmayr,W., Hechtner,M. (…)Lancet Oncology
QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancerPinto Eleonora, Nardi Maria Teresa, Marchi,R., Cavallin,F., Alfieri Rita, Saadeh,L., Cagol BREAST UNIT Matteo, Baldan,I., Saraceni,E., Parotto,M., Baratto,F., Caberlotto,C., Vianello,A., Castoro,C., Scarpa,M.Supportive Care in Cancer
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapyGiannini,V., Rosati,S., Defeudis,A., Balestra,G., Vassallo,L., Cappello,G., Mazzetti,S., De Mattia,C., Rizzetto,F., Torresin,A., Sartore-Bianchi,A., Siena,S., Vanzulli,A., Leone,F., Zagonel Vittorina, Marsoni,S., Regge,D.International Journal of Cancer
Radiotherapy activities and technological equipment in Veneto, Italy: a report from the Rete Radioterapica VenetaBellometti,S., Nube,G., Alongi,F., Baiocchi,C., Corti Luigi, Di Biase,S., Fiorica,F., Gava,A., Iannone,T., Abu Rumeileh,I., Mazzarotto,R., Testolin,A., Mandoliti,G., On the behalf of “Triveneto group of Italian AssRadiologia Medica
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2Kudo,M., Galle,P. R., Llovet,J. M., Finn,R. S., Vogel,A., Motomura,K., Assenat,E., Merle,P., Brandi,G., Daniele,B., Okusaka,T., Tomasek,J., Borg,C., Dadduzio Vincenzo, Morimoto,M., Pracht,M., Jen,M. H., Drove Ubreva,N., Widau,R. C., Shinozaki,K. (…)Liver International
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): A study protocolBongiovanni,A., Liverani,C., Pusceddu,S., Leo,S., Di Meglio,G., Tamberi,S., Santini,D., Gelsomino,F., Pucci,F., Berardi,R., Lolli,I., Bergamo Francesca, Ricci,S., Foca,F., Severi,S., Ibrahim,T.BMJ Open
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumabCaccese Mario, Barbot,M., Ceccato,F., Padovan,M., Gardiman,M. P., Fassan,M., Denaro,L., Emanuelli,E., D’Avella,D., Scaroni,C., Zagonel Vittorina, Lombardi GiuseppeAnti-Cancer Drugs
Rare Primary Central Nervous System Tumors in Adults: An OverviewFranceschi,E., Frappaz,D., Rudà,R., Hau,P., Preusser,M., Houillier,C., Lombardi Giuseppe, Asioli,S., Dehais,C., Bielle,F., Di Nunno,V., van den Bent,M., Brandes,A. A., Idbaih,A., EURACAN Domain 10Frontiers in Oncology
Re: A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CTEvangelista, L., Sepulcri MatteoClinical nuclear medicine
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208-16Evangelista,L., De Salvo Gian Luca, Zattoni,F., Novara,G.European urology oncology
Reactive oxygen species and antitumor immunity- from surveillance to evasionKotsafti Andromachi, Scarpa,M., Castagliuolo,I., Scarpa MelaniaCancers
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerPasello Giulia, Pavan,A., Attili,I., Bortolami Alberto, Bonanno Laura, Menis Jessica, Conte PierFranco, Guarneri ValentinaCancer treatment reviews
Real-world data for direct stage-specific costs of melanoma healthcareBuja,A., Rivera,M., De Polo,A., Zorzi,M., Carpin,E., Vecchiato Antonella, Del Fiore Santo Paolo, Martin,G., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoThe British journal of dermatology
Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factorsTropea Saveria, Mocellin Simone, Damiani,G. B., Stramare,R., Aliberti,C., Del Fiore Santo Paolo, Rossi Carlo Riccardo, Rastrelli MarcoEuropean Journal of Surgical Oncology
Red and processed meat consumption and risk of depression: A systematic review and meta-analysisNucci Daniele, Fatigoni,C., Amerio,A., Odone,A., Gianfredi,V.International Journal of Environmental Research and Public Health
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With NivolumabNarducci,M. G., Tosi,A., Frezzolini,A., Scala,E., Passarelli,F., Bonmassar,L., Monopoli,A., Accetturi,M. P., Cantonetti,M., Antonini Cappellini,G. C., De Galitiis,F., Rosato Antonio, Picozza,M., Russo,G., D’Atri,S.Frontiers in immunology
Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergencyGiancarla,F., Cristina,T., Teresa,S., Andrea,M., Vittoria,S., Enzo,M., Mario,C., Battista,R. G., Fantin Alberto, Realdon Stefano, Ippazio,U., Renato,C.Digestive and Liver Disease
Repeat Screening Outcomes with Digital Breast Tomosynthesis Plus Synthetic Mammography for Breast Cancer Detection: Results from the Prospective Verona Pilot StudyCaumo Francesca, Montemezzi,S., Romanucci,G., Brunelli,S., Bricolo,P., Cugola,L., Gennaro Gisella MariaRadiology
Reply to the Letter to the Editor: ‘Mammography dose estimates do not reflect any specific patient’s breast dose’Gennaro Gisella Maria, Bigolaro,S., Stramare,R., Hill,M. L., Caumo FrancescaEuropean Journal of Radiology
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical propertiesPanciera,T., Citron,A., Di Biagio,D., Battilana,G., Gandin,A., Giulitti,S., Forcato,M., Bicciato,S., Panzetta,V., Fusco,S., Azzolin,L., Totaro,A., Dei Tos,A. P., Fassan,M., Vindigni,V., Bassetto,F., Rosato Antonio, Brusatin,G., Cordenonsi,M., Piccolo,S. (…)Nature Materials
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional AnalysisRossini,D., Germani,M. M., Pagani,F., Pellino,A., Dell’Aquila,E., Bensi,M., Liscia,N., Moretto,R., Boccaccino,A., Prisciandaro,M., Manglaviti,S., Schirripa Marta, Vivolo,R., Scartozzi,M., Santini,D., Salvatore,L., Pietrantonio,F., Loupakis Fotios, Falcone,A., Cremolini,C. (…)Clinical Colorectal Cancer
Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of Literature on a Neglected Issue Revived in the COVID-19 Pandemic EraPavan,N., CRESTANI ALESSANDRO, Abrate,A., Nunzio,C., Esperto,F., Giannarini,G., Galfano,A., Gregori,A., Liguori,G., Bartoletti,R., Porpiglia,F., Simonato,A., Trombetta,C., Tubaro,A., Ficarra,V., Novara,G., Research Urology Network (RUN)European urology focus
Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional TreatmentsCalabrò Maria Luisa, Lazzari,N., Rigotto,G., Tonello Marco, Sommariva AntonioInternational Journal of Molecular Sciences
Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predispositionAgata Simona, Tognazzo Silvia, Alducci Elisa, Matricardi Laura, Moserle Lidia, Barana,D., Montagna MarcoScientific Reports
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot StudyCavedon Elisabetta, Manso,J., Negro,I., Censi,S., Serra,R., Busetto,L., Vettor,R., Plebani,M., Pezzani,R., Nacamulli,D., Mian,C.International Journal of Endocrinology
Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapyMagbanua,M. J. M., Hendrix,L. H., Hyslop,T., Barry,W. T., Winer,E. P., Hudis,C., Toppmeyer,D., Carey,L. A., Partridge,A. H., Pierga,J. Y., Fehm,T., Vidal-Martínez,J., Mavroudis,D., Garcia-Saenz,J. A., Stebbing,J., Gazzaniga,P., Manso,L., Zamarchi Rita, Antelo,M. L., De Mattos-Arruda,L. (…)Journal of the National Cancer Institute
Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinomaKelley,R. K., Meyer,T., Rimassa,L., Merle,P., Park,J. W., Yau,T., Chan,S. L., Blanc,J. F., Tam,V. C., Tran,A., Dadduzio Vincenzo, Markby,D. W., Kaldate,R., Cheng,A. L., El-Khoueiry,A. B., Abou-Alfa,G. K.Clinical Cancer Research
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panelLorusso,D., Bologna,A., Cecere,S. C., De Matteis,E., Scandurra,G., Zamagni,C., Arcangeli,V., Artioli,F., Bella,M., Blanco,G., Cardalesi,C., Casartelli,C., De Vivo,R., Di Napoli,M., Gisone,E. B., Lauria,R., Lissoni,A. A., Loizzi,V., Maccaroni,E., Mangili,G. (…)Supportive Care in Cancer
SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemiaGarcì­a-Canaveras,J. C., Lancho,O., Ducker,G. S., Ghergurovich,J. M., Xu,X., da Silva-Diz,V., Minuzzo,S., Indraccolo Stefano, Kim,H., Herranz,D., Rabinowitz,J. D.Leukemia
Should triple-positive breast cancer be recognized as a distinct subtype?Dieci Maria Vittoria, Guarneri ValentinaExpert Review of Anticancer Therapy
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE TrialSuenaga,M., Schirripa Marta, Cao,S., Zhang,W., Yang,D., Cremolini,C., Murgioni Sabina, Lonardi Sara, Ning,Y., Okazaki,S., Berger,M. D., Miyamoto,Y., Barzi,A., Loupakis Fotios, Falcone,A., Lenz,H. J.Cancers
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastomaCastellan,M., Guarnieri,A., Fujimura,A., Zanconato,F., Battilana,G., Panciera,T., Sladitschek,H. L., Contessotto,P., Citron,A., Grilli,A., Romano,O., Bicciato,S., Fassan,M., Porcù,E., Rosato Antonio, Cordenonsi,M., Piccolo,S.Nature Cancer
SMO mutations confer poor prognosis in malignant pleural mesotheliomaSignorelli,D., Proto,C., Botta,L., Trama,A., Tiseo,M., Pasello Giulia, Russo,G. L., Fabbri,A., Imbimbo,M., Busico,A., Prelaj,A., Ferrara,R., Galli,G., de Toma,A., Tamborini,E., Pastorino,U., de Braud,F., Gatta,G., Garassino,M. C., Ganzinelli,M. (…)Translational lung cancer research
Solitary biceps muscle metastasis from neuroendocrine breast tumorCelotto,F., Tropea Saveria, Rastrelli Marco, Saibene Tania, Gazzetta,G., Dieci Maria Vittoria, Scapinello Antonio, Michieletto SilviaBreast Journal
Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience Iafrate,M., Motterle,G., Zaborra,C., Leone,N., Prayer-Galetti,T., Zattoni,F., Guttilla,A., Cappellesso,R., Dei Tos,A. P., Rossi Carlo Riccardo, Del Fiore Santo Paolo, Rastrelli Marco, Mocellin SimoneFrontiers in surgery
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancerAttili,I., Bonanno Laura, Karachaliou,N., Bracht,J. W. P., Berenguer,J., Codony-Servat,C., Codony-Servat,J., Aldeguer,E., Gimenez-Capitan,A., Dal Maso,A., Fassan,M., Chaib,I., Molina-Vila,M. A., Passaro,A., de Marinis,F., Pasello Giulia, Guarneri Valentina, Conte PierFranco, Rosell,R.Translational lung cancer research
State of the art and trends of circulating cancer biomarkersGion,M., Trevisiol Chiara, Fabricio,A. S. C.International Journal of Biological Markers
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOGBersanelli,M., Giannarelli,D., De Giorgi,U., Pignata,S., Di Maio,M., Verzoni,E., Clemente,A., Guadalupi,V., Signorelli,D., Tiseo,M., Giusti,R., Filetti,M., Di Napoli,M., Calvetti,L., Cappetta,A., Ermacora,P., Zara,D., Barbieri,F., Baldessari,C., Scotti,V. (…)Therapeutic advances in medical oncology
Synchronous nodal metastatic risk in screening detected and endoscopically removed pT1 colorectal cancersCappellesso,R., Nicolè,L., Zanco,F., Lo Mele,M., Fassina,A., Ventura,L., Rosa-Rizzotto,E., Guido,E., De Lazzari,F., Pilati Pierluigi, Tonello Marco, Fassan,M., Rugge,M.Pathology, research and practice
Synthesis and preclinical evaluation of the 99mTc-/177Lu-CXCR4-L theranostic pair for in vivo chemokine-4 receptor-specific targetingÁvila-Sánchez,M., Ferro-Flores,G., Jiménez-Mancilla,N., Ocampo-Garcìa,B., Bravo-Villegas,G., Luna-Gutierrez,M., Santos-Cuevas,C., Azorì­n-Vega,E., Aranda-Lara,L., Isaac-Olivè,K., Melendez-Alafort LauraJournal of Radioanalytical and Nuclear Chemistry
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelCarbognin,L., Simbolo,M., Caliò,A., Vicentini,C., Delfino,P., Sperduti,I., Fassan,M., Schettini,F., Dieci Maria Vittoria, Griguolo Gaia, Pilotto,S., Fiorio,E., Arpino,G., Guarneri Valentina, De Placido,S., Conte PierFranco, Manfrin,E., Brunelli,M., Scambia,G., Scarpa,A. (…)Breast
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsulesPinton Laura, Magri,S., Masetto Elena, Vettore,M., Schibuola,I., Ingangi Vincenzo, Marigo Ilaria , Matha,K., Benoit,J. -P, Della Puppa,A., Bronte,V., Lollo,G., Mandruzzato SusannaJournal of Nanobiotechnology
Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditionsSernicola,A., Russo,I., Silic-Benussi Micol, Ciminale Vincenzo, Alaibac,M.Expert Opinion on Biological Therapy
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?Novara,G., Checcucci,E., CRESTANI ALESSANDRO, Abrate,A., Esperto,F., Pavan,N., De Nunzio,C., Galfano,A., Giannarini,G., Gregori,A., Liguori,G., Bartoletti,R., Porpiglia,F., Scarpa,R. M., Simonato,A., Trombetta,C., Tubaro,A., Ficarra,V., Research Urology Network (RUN)European Urology
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping MutationsPaik,P. K., Felip,E., Veillon,R., Sakai,H., Cortot,A. B., Garassino,M. C., Mazieres,J., Viteri,S., Senellart,H., Van Meerbeeck,J., Raskin,J., Reinmuth,N., Conte PierFranco, Kowalski,D., Cho,B. C., Patel,J. D., Horn,L., Griesinger,F., Han,J. Y., Kim,Y. C. (…)The New England Journal of Medicine
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinomaBoscolo-Rizzo,P., Giunco,S., Rampazzo,E., Brutti Martina, Spinato,G., Menegaldo,A., Stellin,M., Mantovani,M., Bandolin,L., Rossi,M., Del Mistro Annarosa, Tirelli,G., Dei Tos,A. P., Guerriero,A., Niero,M., Da Mosto,M. C., Polesel,J., De Rossi AnitaJournal of cancer research and clinical oncology
TERT promoter mutations differently correlate with the clinical outcome of MAPK inhibitor-treated melanoma patientsDel Bianco Paola, Stagni,C., Giunco,S., Fabozzi Alessio, Elefanti Lisa, Pellegrini,S., Vecchiato Antonella, Pigozzo Jacopo, Zamuner Diagnostica Melanomi Sarcomi Carolina, De Rossi Anita, De Nicolo Arcangela, Menin ChiaraCancers
Testosterone is sequestered in dysfunctional adipose tissue, modifying androgen-responsive genesDi Nisio,A., Sabovic,I., De Toni,L., Rocca Maria Santa, Dall’Acqua,S., Azzena,B., De Rocco Ponce,M., Foresta,C.International Journal of Obesity
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathyCastellani,F., Visentin,A., Campagnolo,M., Salvalaggio,A., Cacciavillani,M., Candiotto Cinzia, Bertorelle Roberta, Trentin,L., Briani,C.Neurology-Neuroimmunology & Neuroinflammation
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophagesMarigo Ilaria , Trovato,R., Hofer,F., Ingangi Vincenzo, DE Sanctis,F., Ugel,S., Cane,S., Simonelli,A., Lamolinara,A., Iezzi,M., Fassan,M., Rugge,M., Boschi,F., Borile,G., Eisenhaure,T., Sarkizova,S., Lieb,D., Hacohen,N., Azzolin,L., Piccolo,S. (…)Cancer Discovery
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancerFanelli,G. N., Dal Pozzo,C. A., Depretis Ilaria, Schirripa Marta, Brignola,S., Biason Paola, Balistreri,M., Dal Santo,L., Lonardi Sara, Munari Giada, Loupakis Fotios, Fassan,M.Cancer Cell International
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastasesBasso,M., Corallo,S., Calegari,M. A., Zurlo,I. V., Ardito,F., Vellone,M., Marchesani,S., Orlandi,A., Dadduzio Vincenzo, Fucà ,G., Di Dio,C., Mele,C., Barbaro,B., Strippoli,A., Coppola,A., Cassano,A., Bria,E., Barone,C. A., Giuliante,F.Scientific Reports
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trialsFucà ,G., Guarini,V., Antoniotti,C., Morano,F., Moretto,R., Corallo,S., Marmorino,F., Lonardi Sara, Rimassa,L., Sartore-Bianchi,A., Borelli,B., Tampellini,M., Bustreo,S., Claravezza,M., Boccaccino,A., Murialdo,R., Zaniboni,A., Tomasello,G., Loupakis Fotios, Adamo,V. (…)British Journal of Cancer
The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practiceGonzalez-Ericsson,P., Stovgaard,E. S., Sua,L. F., Reisenbichler,E., Kos,Z., Carter,J. M., Michiels,S., Le Quesne,J., Nielsen,T. O., Lænkholm,A. -V, Fox,S. B., Adam,J., Bartlett,J. M. S., Rimm,D. L., Quinn,C., Peeters,D., Dieci Maria Vittoria, Vincent-Salomon,A., Cree,I., Hida,A. I. (…)Journal of Pathology
The Pathologic and Molecular Landscape of Esophageal Squamous Cell CarcinogenesisBusinello,G., Parente,P., Mastracci,L., Pennelli,G., Traverso Giulia, Milione,M., Bellan,E., Michelotto,M., Kotsafti Andromachi, Grillo,F., Fassan,M.Cancers
The prognostic impact of the extent of ulceration in patients with clinical stage I-II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI)Portelli,F., Galli,F., Cattaneo,L., Cossa,M., De Giorgi,V., Forte,G., Fraternali Orcioni,G., Gianatti,A., Indini,A., Labianca,A., Maurichi,A., Merelli,B., Montesco, MC., Occelli,M., Patuzzo,R., Piazzalunga,D., Pigozzo Jacopo, Quaglino,P., Ribero,S., Salvatori,R. (…)The British journal of dermatology
The prognostic value of pain in castration-sensitive prostate cancerIacovelli,R., Ciccarese,C., Caffo,O., De Giorgi,U., Tucci,M., Mosillo,C., Bimbatti Davide, Pierantoni,F., Maines,F., Casadei,C., Buttigliero,C., Milella,M., Tortora,G.Prostate cancer and prostatic diseases
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with SorafenibCaputo,F., Dadduzio Vincenzo, Tovoli,F., Bertolini,G., Cabibbo,G., Cerma,K., Vivaldi,C., Faloppi,L., Rizzato,M. D., Piscaglia,F., Celsa,C., Fornaro,L., Marisi,G., Conti,F., Silvestris,N., Silletta,M., Lonardi Sara, Granito,A., Stornello,C., Massa,V. (…)PLoS ONE
The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal CancerEvangelista Laura, Basso Umberto, Maruzzo Marco, Novara,G.European urology focus
The sacral chordoma marginRadaelli,S., Fossati,P., Stacchiotti,S., Akiyama,T., Asencio,J.M., Bandiera,S., Boglione,A., Boland,P., Bolle,S., Bruland,O., Brunello Antonella, Bruzzi,P., Campanacci,D., Cananzi,F., Capanna,R., Casadei,R., Cordoba,A., Court,C., Dei Tos,A.P., DeLaney,T.F. (…)European Journal of Surgical Oncology
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and RealityFerrari,D., Ghi Maria Grazia, Franzese,C., Codecà ,C., Gau,M., Fayette,J.Frontiers in Oncology
The tumor microenvironment of primitive and metastatic breast cancer: Implications for novel therapeutic strategiesZarrilli,G., Businello,G., Dieci Maria Vittoria, Paccagnella,S., Carraro,V., Cappellesso,R., Miglietta,F., Griguolo Gaia, Guarneri Valentina, Mele,M. L., Fassan,M.International Journal of Molecular Sciences
The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR studyGacci,M., Greco,I., Artibani,W., Bassi,P., Bertoni,F., Bracarda,S., Briganti,A., Carmignani,G., Carmignani,L., Conti,G., Corvò,R., De Nunzio,C., Fusco,F., Graziotti,P., Maggi,S., Magrini,S. M., Mirone,V., Montironi,R., Muto,G., Noale,M. (…)Minerva urologica e nefrologica
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureThanopoulou,E., Khader,L., Caira,M., Wardley,A., Ettl,J., MIGLIETTA FEDERICA, Neven,P., Guarneri ValentinaCancers
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trialPasqualetti,G., Schirripa Marta, Dochy,E., Fassan,M., Ziranu,P., Puzzoni,M., Scartozzi,M., Alberti,G., Lonardi Sara, Zagonel Vittorina, Monzani,F., Loupakis FotiosEuropean Journal of Cancer
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancerRugo,H. S., Andrè,F., Yamashita,T., Cerda,H., Toledano,I., Stemmer,S. M., Jurado,J. C., Juric,D., Mayer,I., Ciruelos,E. M., Iwata,H., Conte PierFranco, Campone,M., Wilke,C., Mills,D., Lteif,A., Miller,M., Gaudenzi,F., Loibl,S.Annals of Oncology
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mandalà ,M., Galli,F., Patuzzo,R., Maurichi,A., Mocellin Simone, Rossi Carlo Riccardo, Rulli,E., Montesco,M., Quaglino,P., Caliendo,V., De Giorgi,V., Merelli,B., Caracò,C., Piazzalunga,D., Labianca,A., Ribero,S., Senetta,R., Gianatti,A., Valeri,B., Massi,D. (…)European Journal of Cancer
To transplant or not to transplant during the SARS COV 2 pandemic? That is the questionMarino Dario, Finotto Silvia, Basso Umberto, Galiano,A., Bolshinsky Maital, Amato,O., Marson,P., Tison,T., Colpo,A., Zagonel VittorinaOncologist
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard ChemotherapyGraziano,F., Fischer,N. W., Bagaloni,I., Di Bartolomeo,M., Lonardi Sara, Vincenzi,B., Perrone,G., Fornaro,L., Ongaro,E., Aprile,G., Bisonni,R., Prisciandaro,M., Malkin,D., Garièpy,J., Fassan,M., Loupakis Fotios, Sarti,D., Del Prete,M., Catalano,V., Alessandroni,P. (…)Cancers
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS StudyCortinovis,D., Grosso,F., Carlucci,L., Zucali,P. A., Pasello Giulia, Tiseo,M., Sperandi,F., Hollander,L., Galli,F., Torri,V., Rulli,E., Canova,S., Maconi,A., Bidoli,P., Ceresoli,G. L., D’Incalci,M., ATREUS investigatorsClinical Lung Cancer
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusFeng,H., Gusev,A., Pasaniuc,B., Wu,L., Long,J., Abu-full,Z., Aittomäki,K., Andrulis,I. L., Anton-Culver,H., Antoniou,A. C., Arason,A., Arndt,V., Aronson,K. J., Arun,B. K., Asseryanis,E., Auer,P. L., Azzollini,J., Balmaña,J., Barkardottir,R. B., Barnes,D. R. (…)Genetic Epidemiology
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective studyButi,S., Bersanelli,M., Viansone,A., Leonetti,A., Masini,C., Ratta,R., Procopio,G., Maines,F., Iacovelli,R., Ciccarese,C., Vitale,M. G., De Giorgi,U., Mucciarini,C., Maruzzo Marco, Prati,G., Lattanzi,E., Ciammella,P., Bruni,A., Andreani,S., D’Abbiero,N. (…)Cancer Treatment and Research Communications
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONORossini,D., Lonardi Sara, Antoniotti,C., Santini,D., Tomasello,G., Ermacora,P., Germani,M. M., Bergamo Francesca, Ricci,V., Caponnetto,S., Moretto,R., Zaniboni,A., Pietrantonio,F., Buonadonna,A., Ritorto,G., Masi,G., Latiano,T. P., Rapisardi,S., Falcone,A., Cremolini,C. (…)British Journal of Cancer
Typical values for pediatric interventional cardiology catheterizations: A standardized approach towards Diagnostic Reference Level establishmentDe Monte Francesca, Castaldi,B., Branchini,M., Bettinelli Andrea, Milanesi,O., Paiusco Marta, Roggio AntonellaPhysica Medica
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialCremolini,C., Antoniotti,C., Rossini,D., Lonardi Sara, Loupakis Fotios, Pietrantonio,F., Bordonaro,R., Latiano,T. P., Tamburini,E., Santini,D., Passardi,A., Marmorino,F., Grande,R., Aprile,G., Zaniboni,A., Murgioni Sabina, Granetto,C., Buonadonna,A., Moretto,R., Corallo,S. (…)Lancet Oncology
Urology practice during the COVID-19 pandemicFicarra,V., Novara,G., Abrate,A., Bartoletti,R., CRESTANI ALESSANDRO, De Nunzio,C., Giannarini,G., Gregori,A., Liguori,G., Mirone,V., Pavan,N., Scarpa,R. M., Simonato,A., Trombetta,C., Tubaro,A., Porpiglia,F., Research Urology Network (RUN)Minerva urologica e nefrologica
Use of antibiotic prophylaxis is not needed for endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts: a meta-analysisFacciorusso,A., Mohan,B. P., Tacelli,M., Crinò,S. F., Antonini,F., Fantin Alberto, Barresi,L.Expert Review of Gastroenterology & Hepatology
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenibCasadei-Gardini,A., Dadduzio Vincenzo, Rovesti,G., Cabibbo,G., Vukotic,R., Rizzato,M. D., Orsi,G., Rossi,M., Guarneri,V., Lonardi Sara, D’agostino,D., Celsa,C., Andreone,P., Zagonel Vittorina, Scartozzi,M., Cascinu,S., Cucchetti,A.Medicine
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerMiglietta,F., Dieci Maria Vittoria, Tsvetkova,V., Griguolo Gaia, Vernaci,G., Menichetti,A., Faggioni Giovanni, Giarratano Tommaso, Mioranza Eleonora, Genovesi,E., Cumerlato,E., Bottosso,M., Saibene Tania, Michieletto Silvia, Lo Mele,M., Conte PierFranco, Guarneri ValentinaOncologist
Von Hippel-Lindau disease and multispecialist teamPavesi,G., Feletti,A., Ferrara Alfonso Massimiliano, Anglani,M., Scarpa,B., Schiavi Francesca, Boaretto Francesca, Zovato Stefania, Taschin Elisa, Gardi,M., Zanoletti,E., Piermarocchi,S., Murgia,A., Opocher Giuseppe, VHL-Padova NetworkJournal of neurosurgical sciences
What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plansHernandez,V., Ronn Hansen,C., Widesott,L., Back,A., Canters,R., Fusella Marco, Gostedt,J., Jurado-Bruggeman,D., Mukumoto,N., Patricia Kaplan,L., Koniarová,I., Piotrowski,T., Placidi,L., Vaniqui,A., Jornet,N.Radiotherapy and Oncology
Wnt/?-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and CatsSammarco,A., Gomiero,C., Sacchetto,R., Beffagna,G., Michieletto Silvia, Orvieto,E., Cavicchioli,L., Gelain,M. E., Ferro,S., Patruno,M., Zappulli,V.Veterinary Pathology
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: A clinical and molecular proof of concept studyCremolini,C., Benelli,M., Fontana,E., Pagani,F., Rossini,D., Fucà,G., Busico,A., Conca,E., Di Donato,S., Loupakis Fotios, Schirripa Marta, Lonardi Sara, Borelli,B., Ongaro,E., Eason,K., Morano,F., Casagrande,M., Fassan,M., Sadanandam,A., De Braud,F. (…)ESMO Open
Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategyPastò Anna, Giordano,F., Evangelopoulos,M., Amadori Alberto, Tasciotti,E.Clinical and translational medicine
Comparison of Pheochromocytoma-Specific Morbidity and Mortality among Adults with Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing AdrenalectomyNeumann,H. P. H., Tsoy,U., Bancos,I., Amodru,V., Walz,M. K., Tirosh,A., Kaur,R. J., McKenzie,T., Qi,X., Bandgar,T., Petrov,R., Yukina,M. Y., Roslyakova,A., Van Der Horst-Schrivers,A. N. A., Berends,A. M. A., Hoff,A. O., Castroneves,L. A., Ferrara Alfonso Massimiliano, Rizzati Silvia, Mian,C. (…)JAMA network open
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancerEvangelista Laura, Cuppari Lea, Burei Marta, Zorz Alessandra, Caumo FrancescaClinical and Translational Imaging
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerRobson,M. E., Tung,N., Conte PierFranco, Im,S. A., Senkus,E., Xu,B., Masuda,N., Delaloge,S., Li,W., Armstrong,A., Wu,W., Goessl,C., Runswick,S., Domchek,S. M.Annals of Oncology
Reflectance Confocal Microscopy in Evaluating Skin Cancer: A Clinicians’s PerspectiveFiloni Angela, Alaibac,M.Frontiers in Oncology
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicineCarpanese Debora, Zorz Alessandra, Evangelista Laura, Salvarese,N.Clinical and Translational Imaging
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerFiglioli,G., Bogliolo,M., Catucci,I., Caleca,L., Lasheras,S. V., Pujol,R., Kiiski,J. I., Muranen,T. A., Barnes,D. R., Dennis,J., Michailidou,K., Bolla,M. K., Leslie,G., Aalfs,C. M., Balleine,R., Baxter,R., Braye,S., Carpenter,J., Dahlstrom,J., Forbes,J. (…)NPJ breast cancer

Dati aggiornati al 7 gennaio 2021.

Ultima modifica: 20/01/2021 11:04

Torna su